drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Amiodarone	Acenocoumarol	0.332	-2.015	None	3312 (1180/2132)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#AFCEE4	414.572628443037	0
Omeprazole	Alprazolam	0.283	2.192	Moderate	25496 (18096/7400)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F7B7B7	3191.40813248299	1
Omeprazole	Diazepam	0.246	1.784	Moderate	30997 (20632/10365)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F7B9B9	3879.98422821522	1
Haloperidol	Biperiden	0.499	-1.058	Moderate	339 (174/165)		#B4D1E6	42.4336114257819	0
Digoxin	Furosemide	0.351	-1.345	Moderate	2793 (1266/1527)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#B2D0E5	349.60789590622	0
Digoxin	Spironolactone	0.354	-1.157	Minor	988 (485/503)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#B4D1E6	123.670820320568	0
Alendronic acid	Ibuprofen	0.159	15.126	Moderate	9562 (9027/535)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#D87373	1196.90322257618	1
Indomethacin	Methotrexate	0.277	1.459	Major	683 (423/260)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F8BABA	85.4930873268702	0
Acetylsalicylic acid	Ibuprofen	0.125	-1.581	Major	22301 (9226/13075)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#B2D0E5	2791.48073276213	1
Acetaminophen	Acenocoumarol	0.212	-1.39	None	11094 (4940/6154)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	1388.6680978101	1
Acetylsalicylic acid	Gliclazide	0.361	-2.555	None	7898 (2400/5498)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	988.615525194174	3.90823076940289e-160
Omeprazole	Clonazepam	0.245	1.555	Moderate	6378 (4046/2332)		#F8BABA	798.352724700993	1
Acetylsalicylic acid	Insulin aspart	0.312	-1.792	Moderate	3761 (1443/2318)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#B1CFE5	470.775258325562	0
Mesalazine	Azathioprine	0.367	-1.673	Moderate	250 (100/150)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B1CFE5	31.2932237653259	1.86367179366164e-288
Acetylsalicylic acid	Glyburide	0.33	-2.426	Moderate	4689 (1477/3212)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#AECDE3	586.935704942452	2.45630606794852e-192
Omeprazole	Methotrexate	0.302	1.469	Major	3481 (2162/1319)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F8BABA	435.726847708397	3.78502472845157e-21
Trimethoprim	Leucovorin	0.545	-2.252	Major	474 (157/317)		#AECDE3	59.3319522590578	0
Entacapone	Apomorphine	0.209	-3.068	Moderate	15 (4/11)		#ABCBE2	1.87759342591955	1.23103107718677e-34
Risperidone	Donepezil	0.298	1.139	Moderate	193 (108/85)		#F9BCBC	24.1583687468316	2.78221898506887e-173
Rivastigmine	Quetiapine	0.312	-1.236	Moderate	253 (120/133)		#B4D1E6	31.6687424505098	3.25522052998286e-229
Donepezil	Quetiapine	0.328	1.067	Moderate	230 (125/105)		#F9BCBC	28.7897658640998	2.25963157295459e-186
Diclofenac	Alendronic acid	0.134	14.043	Moderate	3333 (3133/200)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#DA7878	417.201259239324	1
Atenolol	Ibuprofen	0.145	1.233	Moderate	5704 (3303/2401)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#F9BCBC	713.986193429675	1
Acetylsalicylic acid	Insulin detemir	0.309	-1.752	Moderate	1738 (676/1062)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#B1CFE5	217.550491616545	2.05624800746278e-126
Digoxin	Carvedilol	0.329	-2.744	Moderate	865 (250/615)	Digoxin may increase the bradycardic activities of Carvedilol.	#ACCCE3	108.274554228027	0
Warfarin	Amiodarone	0.318	-2.406	Major	382 (121/261)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#AECDE3	47.8160459134179	1.53788852441967e-242
Bisoprolol	Ibuprofen	0.127	-1.173	Moderate	7831 (3817/4014)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	980.228941225067	1
Digoxin	Amiodarone	0.335	-2.043	Major	538 (190/348)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#AFCEE4	67.3430175429812	5.05689769271383e-229
Propafenone	Acenocoumarol	0.333	1.071	None	349 (190/159)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#F9BCBC	43.6853403763949	9.52766535123384e-140
Pravastatin	Fenofibrate	0.785	-1.956	Major	1231 (447/784)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#AFCEE4	154.087833820465	3.57451199112713e-230
Alendronic acid	Naproxen	0.142	14.549	Moderate	2705 (2548/157)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#DA7676	338.592681140826	1
Methotrexate	Hydroxychloroquine	0.261	2.515	Minor	156 (115/41)		#F5B4B4	19.5269716295633	5.48869614905731e-106
Omeprazole	Ketazolam	0.265	2.618	None	1631 (1215/416)		#F5B4B4	204.156991844986	1
Simvastatin	Clarithromycin	0.066	1.302	Major	3815 (2259/1556)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#F9BCBC	477.534594658873	1
Digoxin	Verapamil	0.388	-1.188	Moderate	287 (139/148)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#B4D1E6	35.9246208825941	2.0969830875314e-123
Galantamine	Risperidone	0.301	-1.275	Moderate	90 (42/48)		#B4D1E6	11.2655605555173	9.63470192912522e-87
Tramadol	Citalopram	0.208	3.994	Major	2335 (1907/428)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F2AEAE	292.278709968144	1
Torasemide	Ibuprofen	0.153	1.704	Moderate	3089 (2024/1065)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F7B9B9	386.659072844366	1
Levothyroxine	Acenocoumarol	0.283	1.886	None	1589 (1077/512)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F7B9B9	198.899730252411	1
Prednisone	Acetylsalicylic acid	0.15	-2.163	Moderate	5746 (1955/3791)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#AFCEE4	719.243455022249	1
Tramadol	Fluoxetine	0.211	6.707	Major	1552 (1369/183)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#EC9F9F	194.268333135143	1
Allopurinol	Acenocoumarol	0.313	-6.415	None	2599 (385/2214)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#9ABEDB	325.324354264328	4.18875615519556e-113
Warfarin	Propafenone	0.268	1.429	Moderate	83 (51/32)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#F8BABA	10.3893502900882	1.22589069847048e-52
Tramadol	Paroxetine	0.187	4.874	Major	1989 (1680/309)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#F0A9A9	248.968888276933	1
Carbamazepine	Levetiracetam	0.492	-1.221	Moderate	155 (74/81)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#B4D1E6	19.401798734502	5.53378888758838e-88
Bisoprolol	Gliclazide	0.33	-2.536	None	2406 (735/1671)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	301.165985517496	1
Furosemide	Ibuprofen	0.195	1.08	Moderate	4042 (2209/1833)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F9BCBC	505.948841837788	1
Diltiazem	Atorvastatin	0.467	-2.641	Moderate	1805 (536/1269)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#ACCCE3	225.937075585653	5.6608036947278e-36
Diltiazem	Simvastatin	0.424	-1.686	Major	2318 (923/1395)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#B1CFE5	290.150770752101	1
Galantamine	Quetiapine	0.348	-1.167	Moderate	88 (43/45)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#B4D1E6	11.0152147653947	2.83823540297002e-69
Trazodone	Donepezil	0.325	1.239	Moderate	162 (94/68)		#F9BCBC	20.2780089999312	8.49468677523137e-86
Trazodone	Rivastigmine	0.284	-1.062	Moderate	162 (83/79)		#B4D1E6	20.2780089999312	2.04279357705277e-93
Omeprazole	Itraconazole	0.116	1.427	Moderate	1848 (1135/713)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F8BABA	231.319510073289	1
Amitriptyline	Duloxetine	0.349	5.755	Major	460 (398/62)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#EEA4A4	57.5795317281996	2.43507864170718e-19
Atenolol	Gliclazide	0.321	-1.513	None	1282 (544/738)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	160.471651468591	1
Spironolactone	Enalapril	0.35	-2.147	Major	2030 (694/1336)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#AFCEE4	254.100976974446	1
Propranolol	Ibuprofen	0.155	1.555	Moderate	1742 (1105/637)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F8BABA	218.051183196791	1
Repaglinide	Gliclazide	0.24	-1.519	None	614 (260/354)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	76.8561575676403	5.79602097889157e-13
Fenofibrate	Atorvastatin	0.413	-3.12	Major	1872 (493/1379)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#A9C9E1	234.32365955476	5.5182259694115e-05
Bisoprolol	Salbutamol	0.146	-1.69	Moderate	2661 (1058/1603)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#B1CFE5	333.085073758128	1
Levothyroxine	Raloxifene	0.289	31.188	Moderate	680 (661/19)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	85.1175686416863	1
Carbamazepine	Simvastatin	0.347	1.194	Moderate	835 (477/358)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#F9BCBC	104.519367376188	1
Bisoprolol	Insulin aspart	0.29	-1.895	Moderate	977 (362/615)		#B1CFE5	122.293918474893	0.796104460392294
Tacrolimus	Atorvastatin	0.351	-1.779	Moderate	872 (336/536)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#B1CFE5	109.150764493457	1.26494324652889e-05
Acetaminophen	Warfarin	0.222	-1.451	Minor	1291 (561/730)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B2D0E5	161.598207524143	1
Alprazolam	Clarithromycin	0.108	3.134	Moderate	1025 (797/228)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F4B1B1	128.302217437836	1
Acetylsalicylic acid	Insulin glulisine	0.261	-1.616	Moderate	453 (185/268)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#B1CFE5	56.7033214627705	1.88211059747865e-20
Acetylsalicylic acid	Acenocoumarol	0.237	-3.169	None	2896 (754/2142)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#A9C9E1	362.500704097535	1
Simvastatin	Fenofibrate	0.375	-2.119	Major	2204 (760/1444)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#AFCEE4	275.881060715113	1
Propranolol	Primidone	0.228	-1.58	Moderate	87 (36/51)	The metabolism of Propranolol can be increased when combined with Primidone.	#B2D0E5	10.8900418703334	3.7078564642933e-61
Bisoprolol	Formoterol	0.221	-1.86	Moderate	1742 (653/1089)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#B1CFE5	218.051183196791	1
Phenytoin	Lamotrigine	0.496	-1.487	Moderate	63 (27/36)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#B2D0E5	7.88589238886212	1.81059844767187e-46
Propranolol	Paroxetine	0.323	2.735	Moderate	482 (363/119)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F5B4B4	60.3333354195482	1
Fluconazole	Simvastatin	0.094	1.235	Major	1234 (715/519)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	154.463352505648	1
Omeprazole	Midazolam	0.244	1.357	Moderate	646 (389/257)		#F8BABA	80.861690209602	1
Valproic acid	Carbamazepine	0.545	-1.157	Moderate	110 (54/56)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#B4D1E6	13.7690184567434	1.91074287455897e-50
Digoxin	Propafenone	0.317	1.168	Moderate	99 (56/43)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#F9BCBC	12.392116611069	1.13707431882894e-36
Methotrexate	Naproxen	0.212	1.56	Major	633 (402/231)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F8BABA	79.2344425738051	1
Amitriptyline	Fluoxetine	0.328	5.292	Major	497 (425/72)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#EFA6A6	62.2109288454678	1
Omeprazole	Flurazepam	0.249	1.659	Moderate	650 (422/228)		#F7B9B9	81.3623817898472	1
Tramadol	Escitalopram	0.204	3.279	Major	1006 (790/216)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F4B1B1	125.923932431671	1
Prednisone	Acenocoumarol	0.163	-1.676	None	1384 (553/831)		#B1CFE5	173.239286764844	1
Lamotrigine	Carbamazepine	0.545	-1.167	Moderate	88 (43/45)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#B4D1E6	11.0152147653947	5.7009468526216e-50
Cholestyramine	Ursodeoxycholic acid	0.317	1.204	None	82 (47/35)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F9BCBC	10.2641773950269	1.57827827023562e-43
Citalopram	Acenocoumarol	0.323	1.092	None	845 (464/381)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#F9BCBC	105.771096326801	1
Ibuprofen	Carvedilol	0.116	-1.419	Moderate	1727 (760/967)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#B2D0E5	216.173589770871	1
Atenolol	Glyburide	0.323	-1.55	Moderate	717 (300/417)	Atenolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	89.7489657589546	1
Trimethoprim	Rifampicin	0.655	-2.028	Moderate	93 (33/60)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#AFCEE4	11.6410792407012	1.19279849942036e-51
Carvedilol	Insulin aspart	0.292	-3.081	Moderate	474 (126/348)		#ABCBE2	59.3319522590578	1.30479243161821e-72
Bisoprolol	Glyburide	0.29	-2.093	Moderate	1024 (356/668)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#AFCEE4	128.177044542775	1
Diltiazem	Amiodarone	0.347	-2.551	Major	332 (101/231)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#ACCCE3	41.5574011603527	4.86548081212564e-50
Ibuprofen	Acenocoumarol	0.12	-1.584	None	2710 (1120/1590)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	339.218545616132	1
Sucralfate	Lansoprazole	0.258	2.628	Moderate	173 (129/44)		#F5B4B4	21.6549108456055	1.63354642089712e-12
Levofloxacin	Acenocoumarol	0.1	-1.974	None	1069 (386/683)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	133.809824820533	1
Simvastatin	Amiodarone	0.299	-2.289	Major	1456 (477/979)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#AECDE3	182.251735209258	1
Atenolol	Salbutamol	0.143	-1.224	Moderate	1384 (660/724)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#B4D1E6	173.239286764844	1
Spironolactone	Losartan	0.352	-1.617	Major	735 (300/435)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#B1CFE5	92.002077870058	1
Ranitidine	Acenocoumarol	0.274	-1.478	None	802 (345/457)		#B2D0E5	100.388661839165	1
Citalopram	Propranolol	0.296	2.165	Moderate	444 (314/130)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F7B7B7	55.5767654072187	1
Fluvoxamine	Olanzapine	0.505	1.025	Moderate	60 (32/28)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#F9BCBC	7.51037370367821	6.27587164851969e-35
Propranolol	Rizatriptan	0.277	3.157	Moderate	104 (81/23)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#F4B1B1	13.0179810863756	4.20738331792719e-22
Bisoprolol	Repaglinide	0.341	-2.541	Moderate	895 (273/622)		#ACCCE3	112.029741079867	1
Fluoxetine	Acenocoumarol	0.275	1.502	None	511 (320/191)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F8BABA	63.9633493763261	1
Paroxetine	Acenocoumarol	0.309	1.415	None	660 (404/256)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	82.6141107404603	1
Amitriptyline	Salbutamol	0.178	2.734	Moderate	737 (555/182)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#F5B4B4	92.2524236601806	1
Raloxifene	Estriol	0.237	27.119	None	125 (121/4)		#BC3434	15.6466118826629	2.13626554065107e-28
Simvastatin	Gemfibrozil	0.233	-2.176	Major	1812 (614/1198)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#AFCEE4	226.813285851082	1
Acetylsalicylic acid	Glipizide	0.362	-2.156	Moderate	349 (119/230)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#AFCEE4	43.6853403763949	2.05993494082179e-20
Digoxin	Levothyroxine	0.329	1.952	Moderate	467 (320/147)		#F7B7B7	58.4557419936287	1
Metformin	Glucosamine	0.177	1.107	None	1142 (631/511)		#F9BCBC	142.947446160009	1
Valproic acid	Acetylsalicylic acid	0.375	-1.9	Moderate	646 (239/407)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#B1CFE5	80.861690209602	1
Levothyroxine	Iron	0.163	5.642	Moderate	423 (365/58)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#EEA4A4	52.9481346109313	1
Omeprazole	Halazepam	0.248	2.021	Moderate	423 (293/130)		#F7B7B7	52.9481346109313	1
Mesalazine	Mercaptopurine	0.288	-1.275	Moderate	15 (7/8)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#B4D1E6	1.87759342591955	2.73648506318779e-15
Atorvastatin	Clarithromycin	0.087	-1.219	Major	1258 (601/657)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#B4D1E6	157.46750198712	1
Cyclosporine	Allopurinol	0.336	-3.69	Moderate	168 (39/129)		#A8C8E1	21.029046370299	4.08091971773351e-33
Carbamazepine	Atorvastatin	0.347	-1.207	Moderate	406 (195/211)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#B4D1E6	50.8201953948892	1
Acetylsalicylic acid	Ginkgo biloba	0.228	-1.105	Moderate	621 (312/309)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#B4D1E6	77.7323678330694	1
Cyclosporine	Omeprazole	0.381	-1.736	Moderate	565 (221/344)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B1CFE5	70.7226857096364	1
Indomethacin	Alendronic acid	0.223	6.859	Moderate	372 (329/43)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#EB9E9E	46.5643169628049	1
Phenytoin	Omeprazole	0.32	-1.558	Moderate	676 (282/394)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#B2D0E5	84.6168770614411	1
Hydrocortisone	Acetylsalicylic acid	0.158	-1.487	Moderate	1029 (441/588)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#B2D0E5	128.802909018081	1
Fluoxetine	Propranolol	0.341	3.758	Moderate	270 (218/52)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F2AEAE	33.7966816665519	1
Propranolol	Escitalopram	0.309	2.103	None	271 (190/81)		#F7B7B7	33.9218545616132	1
Propranolol	Sertraline	0.335	2.095	Moderate	317 (222/95)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F7B7B7	39.6798077344332	1
Methotrexate	Amoxicillin	0.107	1.29	Major	834 (492/342)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F9BCBC	104.394194481127	1
Fluvoxamine	Clomipramine	0.423	2.113	Major	47 (33/14)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#F7B7B7	5.88312606788126	6.4838978716965e-22
Simvastatin	Itraconazole	0.076	1.14	Major	861 (482/379)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#F9BCBC	107.773862647782	1
Bisoprolol	Salmeterol	0.273	-2.66	Moderate	1337 (395/942)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#ACCCE3	167.356160696963	1
Digoxin	Hydrochlorothiazide	0.295	-1.062	Moderate	656 (336/320)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#B4D1E6	82.113419160215	1
Verapamil	Atorvastatin	0.4	-1.387	Moderate	451 (201/250)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	56.4529756726478	1
Gliclazide	Carvedilol	0.315	-2.789	None	574 (164/410)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	71.8492417651882	1
Cyclosporine	Ursodeoxycholic acid	0.421	-2.008	Minor	56 (20/36)		#AFCEE4	7.00968212343299	1.70460043143309e-37
Ranolazine	Diltiazem	0.454	-1.115	Major	52 (26/26)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#B4D1E6	6.50899054318778	1.86350805002772e-10
Atorvastatin	Gemfibrozil	0.28	-2.796	Major	1059 (302/757)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#ACCCE3	132.55809586992	1
Fluoxetine	Clomipramine	0.414	2.266	Major	194 (139/55)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F6B6B6	24.2835416418929	6.98573302290139e-10
Citalopram	Clarithromycin	0.112	3.396	Major	541 (428/113)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#F4B1B1	67.7185362281651	1
Venlafaxine	Metoclopramide	0.154	3.699	Moderate	405 (326/79)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F3AFAF	50.6950224998279	1
Dextromethorphan	Paroxetine	0.112	4.108	Major	441 (362/79)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F2ACAC	55.2012467220348	1
Methotrexate	Acetylsalicylic acid	0.27	-1.479	Major	628 (270/358)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#B2D0E5	78.6085780984986	1
Donepezil	Sertraline	0.385	1.746	Minor	112 (74/38)	The metabolism of Donepezil can be decreased when combined with Sertraline.	#F7B9B9	14.019364246866	8.18740336642976e-16
Erythromycin	Simvastatin	0.071	1.547	Major	635 (402/233)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#F8BABA	79.4847883639277	1
Azithromycin	Acenocoumarol	0.092	-1.461	None	963 (417/546)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#B2D0E5	120.541497944035	1
Ciprofloxacin	Acenocoumarol	0.096	-2.813	None	1229 (349/880)		#ABCBE2	153.837488030342	1
Ramipril	Spironolactone	0.368	-2.571	Major	423 (128/295)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#ACCCE3	52.9481346109313	0.00339995466358974
Digoxin	Alprazolam	0.25	1.229	Moderate	403 (233/170)		#F9BCBC	50.4446767097053	1
Citalopram	Carvedilol	0.364	-1.201	Moderate	432 (208/224)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#B4D1E6	54.0746906664831	1
Repaglinide	Glyburide	0.197	-1.963	None	287 (104/183)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#AFCEE4	35.9246208825941	0.173789752002205
Amitriptyline	Carbamazepine	0.394	1.557	Moderate	156 (99/57)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F8BABA	19.5269716295633	4.75012387948154e-09
Methotrexate	Ibuprofen	0.175	1.722	Major	666 (438/228)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F7B9B9	83.3651481108281	1
Paroxetine	Carvedilol	0.355	1.23	Moderate	351 (203/148)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#F9BCBC	43.9356861665175	1
Mirtazapine	Rivastigmine	0.303	1.134	Moderate	77 (43/34)		#F9BCBC	9.63831291972036	6.95887282386953e-19
Fluconazole	Alprazolam	0.15	1.924	Major	387 (264/123)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F7B7B7	48.4419103887244	1
Salbutamol	Carvedilol	0.143	-2.421	Major	780 (246/534)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#AECDE3	97.6348581478167	1
Sertraline	Clarithromycin	0.118	3.658	Moderate	381 (306/75)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F3AFAF	47.6908730183566	1
Fluoxetine	Dextromethorphan	0.121	4.35	Major	316 (262/54)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F1ABAB	39.5546348393719	1
Bisoprolol	Insulin detemir	0.282	-1.943	Moderate	403 (147/256)		#AFCEE4	50.4446767097053	1
Atenolol	Repaglinide	0.295	-1.64	Moderate	410 (166/244)		#B1CFE5	51.3208869751344	1
Cyclosporine	Carvedilol	0.445	-2.632	Moderate	84 (25/59)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#ACCCE3	10.5145231851495	2.98402326549364e-28
Carvedilol	Insulin detemir	0.319	-2.696	Moderate	205 (60/145)		#ACCCE3	25.6604434875672	2.85743523123852e-23
Topiramate	Carbamazepine	0.455	1.345	Moderate	65 (39/26)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#F8BABA	8.13623817898472	3.59380844516938e-17
Acetylsalicylic acid	Methylprednisolone	0.179	-2.159	Moderate	863 (294/569)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#AFCEE4	108.024208437905	1
Simvastatin	Colchicine	0.152	-6.388	Major	1352 (201/1151)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#9ABEDB	169.233754122882	1
Methimazole	Acenocoumarol	0.233	-1.412	None	145 (64/81)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#B2D0E5	18.150069783889	1.85324138261013e-12
Pyridostigmine	Prednisone	0.357	-2.138	Moderate	140 (48/92)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#AFCEE4	17.5242053085825	1.56636423288053e-34
Atenolol	Formoterol	0.188	-1.34	Moderate	667 (303/364)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#B2D0E5	83.4903210058894	1
Enalapril	Tizanidine	0.136	1.019	Major	421 (224/197)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#F9BCBC	52.6977888208087	1
Haloperidol	Lithium cation	0.406	-1.797	Major	47 (18/29)	Lithium may increase the neurotoxic activities of Haloperidol.	#B1CFE5	5.88312606788126	1.3177186030172e-22
Cyclosporine	Atorvastatin	0.417	-1.877	Major	169 (63/106)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#B1CFE5	21.1542192653603	0.00100405809949376
Fluoxetine	Carvedilol	0.36	1.498	Moderate	219 (137/82)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#F8BABA	27.4128640184254	1
Fluoxetine	Risperidone	0.369	1.211	Moderate	174 (100/74)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#F9BCBC	21.7800837406668	0.164990063632974
Olanzapine	Donepezil	0.367	1.473	Moderate	37 (23/14)		#F8BABA	4.63139711726823	3.0614314141448e-10
Glimepiride	Repaglinide	0.205	-1.655	None	154 (62/92)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#B1CFE5	19.2766258394407	1
Trazodone	Galantamine	0.265	-1.455	Moderate	53 (23/30)		#B2D0E5	6.63416343824908	2.90233043329721e-23
Repaglinide	Carvedilol	0.32	-3.497	Moderate	306 (74/232)		#A8C8E1	38.3029058887589	1.38338406210427e-12
Sertraline	Carvedilol	0.343	-1.018	Moderate	264 (138/126)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#B4D1E6	33.0456442961841	1
Fenofibrate	Acenocoumarol	0.299	-3.338	None	503 (126/377)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#A9C9E1	62.9619662158356	1
Paroxetine	Risperidone	0.311	1.173	Moderate	217 (123/94)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#F9BCBC	27.1625182283028	1
Digoxin	Diazepam	0.246	1.177	Moderate	384 (218/166)		#F9BCBC	48.0663917035405	1
Omeprazole	Cilostazol	0.241	-8.327	Major	1202 (142/1060)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#90B6D6	150.457819863687	1
Atenolol	Insulin aspart	0.273	-1.423	Moderate	330 (145/185)		#B2D0E5	41.3070553702301	1
Metoprolol	Prazosin	0.606	1.345	Moderate	5 (3/2)	Metoprolol may increase the orthostatic hypotensive activities of Prazosin.	#F8BABA	0.625864475306517	0.00274892154315656
Carbamazepine	Risperidone	0.395	-1.575	Moderate	82 (34/48)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#B2D0E5	10.2641773950269	5.42317999395345e-19
Fenofibrate	Rosuvastatin	0.47	-3.537	Major	342 (82/260)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#A8C8E1	42.8091301109658	2.69288698023361e-17
Fluoxetine	Nortriptyline	0.392	4.867	Major	45 (38/7)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F0A9A9	5.63278027775865	4.73487814702281e-08
Cyclosporine	Sulfamethoxazole	0.255	-3.416	Major	65 (16/49)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#A8C8E1	8.13623817898472	1.03099864220648e-34
Diltiazem	Amlodipine	0.308	-2.265	Moderate	597 (197/400)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#AECDE3	74.7282183515981	1
Fluoxetine	Clarithromycin	0.114	4.921	Moderate	292 (247/45)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#F0A9A9	36.5504853579006	1
Trihexyphenidyl	Haloperidol	0.486	-1.275	Moderate	15 (7/8)		#B4D1E6	1.87759342591955	9.26424303609296e-09
Fluconazole	Atorvastatin	0.11	-1.388	Major	469 (209/260)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#B2D0E5	58.7060877837513	1
Phenytoin	Vigabatrin	0.594	-1.673	Minor	5 (2/3)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#B1CFE5	0.625864475306517	6.48626592840406e-05
Propranolol	Salbutamol	0.162	-1.14	Major	459 (227/232)		#B4D1E6	57.4543588331383	1
Glimepiride	Gemfibrozil	0.318	-3.172	Moderate	246 (64/182)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#A9C9E1	30.7925321850806	0.000257185937340294
Diazepam	Clarithromycin	0.232	2.154	Moderate	633 (447/186)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F7B7B7	79.2344425738051	1
Topiramate	Lithium cation	0.284	4.124	Moderate	28 (23/5)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#F2ACAC	3.5048410617165	4.7467312445745e-05
Mirtazapine	Donepezil	0.383	2.211	Moderate	52 (37/15)		#F6B6B6	6.50899054318778	0.000184586478138895
Norfloxacin	Acenocoumarol	0.096	1.754	None	337 (223/114)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F7B9B9	42.1832656356593	1
Formoterol	Carvedilol	0.23	-2.839	Major	468 (132/336)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#ABCBE2	58.58091488869	1
Fluvoxamine	Lithium cation	0.323	2.152	Major	17 (12/5)	Lithium may increase the serotonergic activities of Fluvoxamine.	#F7B7B7	2.12793921604216	2.5752057316026e-06
Indomethacin	Losartan	0.159	-1.536	Moderate	435 (183/252)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#B2D0E5	54.450209351667	1
Amiodarone	Flecainide	0.162	-1.54	Major	100 (42/58)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#B2D0E5	12.5172895061303	0.0101191773720739
Tacrolimus	Nifedipine	0.402	-3.404	Moderate	158 (39/119)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#A9C9E1	19.7773174196859	7.46432096836273e-34
Ibuprofen	Lithium cation	0.146	1.349	Moderate	288 (173/115)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F8BABA	36.0497937776554	1
Triamcinolone	Acetylsalicylic acid	0.101	-1.943	Moderate	584 (213/371)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#AFCEE4	73.1009707158012	1
Folic acid	Phenytoin	0.291	-1.673	Moderate	70 (28/42)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#B1CFE5	8.76210265429124	3.73768734191209e-09
Phenytoin	Furosemide	0.33	-1.73	Minor	125 (49/76)	Phenytoin may decrease the diuretic activities of Furosemide.	#B1CFE5	15.6466118826629	0.0214992443019979
Fluoxetine	Lithium cation	0.327	1.295	Major	88 (52/36)	Lithium may increase the serotonergic activities of Fluoxetine.	#F9BCBC	11.0152147653947	2.44735650457699e-06
Spironolactone	Irbesartan	0.306	-1.8	Major	196 (75/121)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#B1CFE5	24.5338874320155	1
Ergotamine	Rizatriptan	0.259	1.517	Major	35 (22/13)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#F8BABA	4.38105132714562	7.95555973727737e-13
Tramadol	Carbamazepine	0.28	1.345	Moderate	250 (150/100)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F8BABA	31.2932237653259	1
Fluvastatin	Acenocoumarol	0.335	-2.083	None	238 (83/155)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#AFCEE4	29.7911490245902	1
Erythromycin	Alprazolam	0.1	4.265	Moderate	190 (157/33)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F2ACAC	23.7828500616477	1
Acetylsalicylic acid	Dexamethasone	0.161	-3.324	Moderate	800 (201/599)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#A9C9E1	100.138316049043	1
Duloxetine	Ciprofloxacin	0.143	1.521	Major	329 (207/122)		#F8BABA	41.1818824751688	1
Olanzapine	Rivastigmine	0.296	1.016	Moderate	32 (17/15)		#F9BCBC	4.00553264196171	2.6087227880647e-08
Propranolol	Gliclazide	0.308	-1.49	None	278 (119/159)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	34.7980648270424	1
Methotrexate	Diclofenac	0.196	1.567	Major	305 (194/111)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F8BABA	38.1777329936975	1
Metoprolol	Ibuprofen	0.144	-1.123	Moderate	279 (139/140)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#B4D1E6	34.9232377221037	1
Zolmitriptan	Paroxetine	0.258	6.137	Major	102 (89/13)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#EDA1A1	12.7676352962529	1
Spironolactone	Cholestyramine	0.273	-1.325	Moderate	70 (32/38)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#B2D0E5	8.76210265429124	3.78059487249337e-07
Fluconazole	Fentanyl	0.371	-1.556	Major	182 (76/106)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#B2D0E5	22.7814669011572	0.0703725215177219
Escitalopram	Rasagiline	0.381	-1.143	Major	83 (41/42)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#B4D1E6	10.3893502900882	0.00027543351599835
Atenolol	Terbutaline	0.11	1.06	Moderate	251 (136/115)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#F9BCBC	31.4183966603872	1
Folic acid	Phenobarbital	0.244	-1.115	Moderate	54 (27/27)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#B4D1E6	6.75933633331038	0.000139627240210632
Atorvastatin	Colchicine	0.181	-6.795	Major	617 (87/530)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#97BCD9	77.2316762528242	1
Atenolol	Salmeterol	0.236	-1.816	Moderate	502 (191/311)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#B1CFE5	62.8367933207743	1
Paroxetine	Rizatriptan	0.273	5.655	Major	95 (82/13)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#EEA4A4	11.8914250308238	1
Salbutamol	Clomipramine	0.142	1.921	Moderate	198 (135/63)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#F7B7B7	24.7842332221381	1
Spironolactone	Tolevamer	0.299	-2.928	Moderate	58 (16/42)		#ABCBE2	7.2600279135556	3.48850264752607e-11
Atenolol	Insulin detemir	0.292	-1.234	Moderate	179 (85/94)		#B4D1E6	22.4059482159733	1
Glyburide	Carvedilol	0.297	-4.137	Moderate	339 (72/267)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#A5C6DF	42.4336114257819	0.360992685595736
Trazodone	Acenocoumarol	0.227	-1.145	None	229 (113/116)		#B4D1E6	28.6645929690385	1
Phenytoin	Oxcarbazepine	0.403	-2.107	Moderate	26 (9/17)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#AFCEE4	3.25449527159389	2.20961430401083e-12
Phenytoin	Quetiapine	0.375	-1.647	Major	52 (21/31)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#B1CFE5	6.50899054318778	3.30460243942087e-10
Levothyroxine	Cholestyramine	0.203	5.273	Moderate	117 (100/17)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#EFA6A6	14.6452287221725	1
Lidocaine	Bisoprolol	0.137	1.114	Moderate	231 (128/103)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#F9BCBC	28.9149387591611	1
Alprazolam	Carbamazepine	0.292	1.573	Moderate	168 (107/61)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F8BABA	21.029046370299	1
Lovastatin	Diltiazem	0.402	1.006	Major	104 (55/49)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#F9BCBC	13.0179810863756	1
Haloperidol	Carbamazepine	0.387	-2.055	Moderate	54 (19/35)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#AFCEE4	6.75933633331038	1.91518101268717e-15
Biperiden	Donepezil	0.376	1.195	Moderate	21 (12/9)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.	#F9BCBC	2.62863079628737	1.40372024795639e-06
Azithromycin	Lovastatin	0.071	1.962	Moderate	220 (151/69)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#F7B7B7	27.5380369134868	1
Fluvoxamine	Mirtazapine	0.361	1.931	Major	41 (28/13)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#F7B7B7	5.13208869751344	0.00108936886239328
Levothyroxine	Warfarin	0.253	1.646	Moderate	156 (101/55)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#F7B9B9	19.5269716295633	1
Gemfibrozil	Acenocoumarol	0.302	-3.939	None	435 (96/339)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#A6C7E0	54.450209351667	1
Cyclosporine	Nifedipine	0.396	-2.603	Moderate	40 (12/28)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#ACCCE3	5.00691580245214	1.60025394164001e-13
Carvedilol	Escitalopram	0.332	-1.47	None	204 (88/116)		#B2D0E5	25.5352705925059	1
Digoxin	Telmisartan	0.327	-1.237	Moderate	116 (55/61)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#B4D1E6	14.5200558271112	1
Citalopram	Rasagiline	0.319	1.241	Major	93 (54/39)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#F9BCBC	11.6410792407012	1
Alprazolam	Itraconazole	0.141	1.83	Major	219 (147/72)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F7B9B9	27.4128640184254	1
Mirtazapine	Rasagiline	0.356	1.13	Major	52 (29/23)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.	#F9BCBC	6.50899054318778	0.626490864520531
Oxycodone	Paroxetine	0.266	3.26	Moderate	102 (80/22)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#F4B1B1	12.7676352962529	1
Phenytoin	Dexamethasone	0.396	-2.055	Moderate	54 (19/35)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#AFCEE4	6.75933633331038	3.35175711471689e-08
Phenytoin	Topiramate	0.51	-1.19	Moderate	31 (15/16)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#B4D1E6	3.88035974690041	1.03793256670757e-07
Citalopram	Rizatriptan	0.242	5.603	Major	87 (75/12)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#EEA4A4	10.8900418703334	1
Sertraline	Rasagiline	0.364	-1.115	Major	84 (42/42)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#B4D1E6	10.5145231851495	1
Spironolactone	Telmisartan	0.343	-1.229	Major	124 (59/65)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#B4D1E6	15.5214389876016	1
Indomethacin	Atenolol	0.147	-2.027	Moderate	324 (115/209)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#AFCEE4	40.5560179998623	1
Sumatriptan	Ergotamine	0.372	1.921	Major	22 (15/7)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#F7B7B7	2.75380369134868	1.01964160226218e-06
Fluconazole	Diazepam	0.273	1.823	Moderate	276 (185/91)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F7B9B9	34.5477190369197	1
Cyclosporine	Rifabutin	0.333	Inf	None	1 (1/0)	The metabolism of Cyclosporine can be increased when combined with Rifabutin.	#B32020	0.125172895061303	1
Oxycodone	Sertraline	0.289	2.567	Moderate	85 (63/22)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F5B4B4	10.6396960802108	1
Fentanyl	Amiodarone	0.241	-1.138	Major	101 (50/51)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#B4D1E6	12.6424624011916	1
Ezetimibe	Cholestyramine	0.228	-1.331	Moderate	68 (31/37)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	8.51175686416863	0.00651233321142671
Citalopram	Oxycodone	0.278	2.119	Moderate	111 (78/33)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F7B7B7	13.8941913518047	1
Rifampicin	Leflunomide	0.096	1.255	Major	12 (7/5)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#F9BCBC	1.50207474073564	0.00235411058134418
Citalopram	Zolmitriptan	0.217	4.867	Major	90 (76/14)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#F0A9A9	11.2655605555173	1
Bisoprolol	Terbutaline	0.102	-1.637	Moderate	343 (139/204)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#B1CFE5	42.9343030060271	1
Galantamine	Sertraline	0.423	1.434	Moderate	39 (24/15)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#F8BABA	4.88174290739083	0.00325535940617737
Fluoxetine	Oxycodone	0.281	2.689	Moderate	80 (60/20)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#F5B4B4	10.0138316049043	1
Fluoxetine	Ergotamine	0.264	6.788	Major	60 (53/7)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#EB9E9E	7.51037370367821	1
Pentoxifylline	Acenocoumarol	0.34	-4.43	None	353 (71/282)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#A3C5DF	44.1860319566401	1
Venlafaxine	Rasagiline	0.353	1.046	Major	65 (35/30)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.	#F9BCBC	8.13623817898472	1
Indomethacin	Furosemide	0.23	-1.909	Moderate	301 (111/190)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#AFCEE4	37.6770414134523	1
Haloperidol	Atropine	1	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Fluvoxamine	Tramadol	0.183	5.603	Major	87 (75/12)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#EEA4A4	10.8900418703334	1
Propranolol	Ergotamine	0.227	2.771	Moderate	45 (34/11)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F5B4B4	5.63278027775865	1
Azathioprine	Acenocoumarol	0.363	-1.181	None	70 (34/36)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#B4D1E6	8.76210265429124	1
Cyclosporine	Sirolimus	0.177	-2.231	Moderate	6 (2/4)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#AECDE3	0.751037370367821	0.00263843622804013
Lorazepam	Phenytoin	0.359	-1.452	Moderate	168 (73/95)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#B2D0E5	21.029046370299	1
Disopyramide	Bisoprolol	0.378	1.153	Major	16 (9/7)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#F9BCBC	2.00276632098085	8.46811998147139e-05
Ergotamine	Nadolol	0.151	2.988	Moderate	13 (10/3)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F5B2B2	1.62724763579694	0.0170100413903518
Propranolol	Maprotiline	0.229	3.227	Minor	23 (18/5)		#F4B1B1	2.87897658640998	0.0475942513992474
Bupropion	Rasagiline	0.377	-1.115	Major	20 (10/10)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.	#B4D1E6	2.50345790122607	0.000921155701634077
Zolmitriptan	Ergotamine	0.187	1.467	Major	29 (18/11)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F8BABA	3.6300139567778	3.89459269735787e-07
Hydrocortisone	Acenocoumarol	0.139	-1.365	None	209 (94/115)		#B2D0E5	26.1611350678124	1
Methotrexate	Flurbiprofen	0.235	1.793	Major	12 (8/4)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#F7B9B9	1.50207474073564	0.01919874597039
Torasemide	Indomethacin	0.161	-1.354	Moderate	186 (84/102)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B2D0E5	23.2821584814024	1
Propranolol	Formoterol	0.2	-1.44	Major	252 (110/142)		#B2D0E5	31.5435695554485	1
Omeprazole	Triazolam	0.263	1.277	Moderate	97 (57/40)		#F9BCBC	12.1417708209464	1
Sucralfate	Levothyroxine	0.16	5.547	Minor	115 (99/16)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#EEA4A4	14.3948829320499	1
Phenytoin	Diazepam	0.286	-1.469	Moderate	139 (60/79)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#B2D0E5	17.3990324135212	1
Indomethacin	Bisoprolol	0.145	-2.735	Moderate	428 (124/304)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#ACCCE3	53.5739990862379	1
Carbamazepine	Sertraline	0.337	1.203	Moderate	96 (55/41)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#F9BCBC	12.0165979258851	1
Atorvastatin	Itraconazole	0.117	-1.186	Major	260 (126/134)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#B4D1E6	32.5449527159389	1
Colestipol	Ursodeoxycholic acid	0.408	7.172	None	9 (8/1)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#EB9C9C	1.12655605555173	0.61183063526292
Sumatriptan	Paroxetine	0.285	5.18	Major	61 (52/9)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#F0A7A7	7.63554659873951	1
Fluoxetine	Rizatriptan	0.226	11.43	Major	55 (51/4)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#E18686	6.88450922837169	1
Ciprofloxacin	Methotrexate	0.098	1.115	Moderate	175 (97/78)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#F9BCBC	21.9052566357281	1
Propranolol	Phenobarbital	0.397	1.345	Moderate	35 (21/14)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#F8BABA	4.38105132714562	1
Enalapril	Lithium cation	0.267	-1.066	Moderate	178 (91/87)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#B4D1E6	22.280775320912	1
Paroxetine	Almotriptan	0.195	8.427	Major	52 (47/5)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#E89696	6.50899054318778	1
Bisoprolol	Verapamil	0.277	-1.23	Major	164 (78/86)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#B4D1E6	20.5283547900538	1
Spironolactone	Captopril	0.324	-1.058	Major	76 (39/37)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#B4D1E6	9.51314002465906	1
Phenytoin	Gabapentin	0.339	-1.115	Moderate	60 (30/30)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#B4D1E6	7.51037370367821	1
Propranolol	Glyburide	0.276	-1.621	Moderate	157 (64/93)	Propranolol may increase the hypoglycemic activities of Glyburide.	#B1CFE5	19.6521445246246	1
Fluoxetine	Carbamazepine	0.362	1.665	Moderate	80 (52/28)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#F7B9B9	10.0138316049043	1
Galantamine	Methotrimeprazine	0.266	4.482	Moderate	6 (5/1)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#F1ABAB	0.751037370367821	1
Fluconazole	Amitriptyline	0.132	3.1	Moderate	107 (83/24)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#F5B2B2	13.3934997715595	1
Warfarin	Acetylsalicylic acid	0.235	-3.839	Major	382 (86/296)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#A6C7E0	47.8160459134179	1
Zolmitriptan	Escitalopram	0.252	5.043	Major	53 (45/8)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#F0A7A7	6.63416343824908	1
Clarithromycin	Acenocoumarol	0.082	-1.278	None	294 (137/157)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#B4D1E6	36.8008311480232	1
Glyburide	Glucosamine	0.213	1.083	None	159 (87/72)		#F9BCBC	19.9024903147472	1
Venlafaxine	Almotriptan	0.194	9.563	Major	35 (32/3)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#E59090	4.38105132714562	1
Duloxetine	Flecainide	0.278	6.147	Moderate	55 (48/7)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#EDA1A1	6.88450922837169	1
Methylprednisolone	Clarithromycin	0.473	1.441	Major	146 (90/56)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F8BABA	18.2752426789503	1
Salmeterol	Carvedilol	0.291	-5.687	Major	433 (71/362)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#9DC0DC	54.1998635615444	1
Moxifloxacin	Acenocoumarol	0.098	-2.299	None	251 (82/169)		#AECDE3	31.4183966603872	1
Mirtazapine	Galantamine	0.381	-1.115	Moderate	28 (14/14)		#B4D1E6	3.5048410617165	0.000377143351474714
Propranolol	Salmeterol	0.247	-1.68	Major	203 (81/122)		#B1CFE5	25.4100976974446	1
Cloxacillin	Acenocoumarol	0.079	-1.768	None	212 (82/130)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#B1CFE5	26.5366537529963	1
Carvedilol	Insulin glulisine	0.252	-3.084	Moderate	64 (17/47)		#ABCBE2	8.01106528392342	2.14227015112814e-07
Atenolol	Diltiazem	0.304	-1.71	Major	228 (90/138)	Diltiazem may increase the hypotensive activities of Atenolol.	#B1CFE5	28.5394200739772	1
Fluconazole	Clonazepam	0.211	1.764	None	92 (61/31)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F7B9B9	11.5159063456399	1
Ibuprofen	Nadolol	0.167	1.376	Moderate	147 (89/58)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#F8BABA	18.4004155740116	1
Tramadol	Rasagiline	0.167	1.255	Major	120 (70/50)	Tramadol may increase the neuroexcitatory activities of Rasagiline.	#F9BCBC	15.0207474073564	1
Pravastatin	Gemfibrozil	0.293	-2.466	Major	244 (76/168)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#AECDE3	30.542186394958	1
Imipramine	Fluoxetine	0.366	1.529	Major	46 (29/17)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F8BABA	5.75795317281996	0.0901183328936124
Omeprazole	Quazepam	0.251	2.057	Moderate	56 (39/17)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#F7B7B7	7.00968212343299	1
Phenytoin	Acenocoumarol	0.314	-2.454	None	80 (25/55)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	10.0138316049043	1
Pregabalin	Pioglitazone	0.253	1.681	Moderate	69 (45/24)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#F7B9B9	8.63692975922994	1
Erythromycin	Citalopram	0.115	5.08	Major	100 (85/15)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#F0A7A7	12.5172895061303	1
Citalopram	Warfarin	0.277	1.345	Moderate	90 (54/36)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#F8BABA	11.2655605555173	1
Tizanidine	Lisinopril	0.122	1.936	Major	79 (54/25)	Tizanidine may increase the hypotensive activities of Lisinopril.	#F7B7B7	9.88865870984297	1
Lovastatin	Acenocoumarol	0.316	-1.573	None	147 (61/86)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#B2D0E5	18.4004155740116	1
Oxycodone	Escitalopram	0.26	1.428	Moderate	70 (43/27)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F8BABA	8.76210265429124	1
Bisoprolol	Insulin glulisine	0.264	-2.26	Moderate	118 (39/79)		#AECDE3	14.7704016172338	1
Ciprofloxacin	Sevelamer	0.185	-1.441	Moderate	55 (24/31)		#B2D0E5	6.88450922837169	1
Sulfasalazine	Azathioprine	0.178	1.494	Moderate	8 (5/3)		#F8BABA	1.00138316049043	0.174634449066423
Rivastigmine	Methotrimeprazine	0.24	1.046	Moderate	13 (7/6)		#F9BCBC	1.62724763579694	0.00923327112051683
Diclofenac	Lithium cation	0.142	1.414	Moderate	116 (71/45)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#F8BABA	14.5200558271112	1
Amiodarone	Levofloxacin	0.177	-3.443	Major	282 (69/213)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#A8C8E1	35.2987564072876	1
Prednisone	Phenobarbital	0.146	1.101	Moderate	78 (43/35)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#F9BCBC	9.76348581478167	1
Almotriptan	Escitalopram	0.267	6.5	Major	33 (29/4)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#EC9F9F	4.13070553702301	1
Spironolactone	Eplerenone	0.117	-5.02	Major	77 (14/63)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#A0C3DD	9.63831291972036	0.000731497730073848
Chlorpropamide	Rifampicin	0.034	Inf	Moderate	1 (1/0)	The serum concentration of Chlorpropamide can be decreased when it is combined with Rifampicin.	#B32020	0.125172895061303	1
Donepezil	Pipotiazine	0.116	Inf	None	1 (1/0)		#B32020	0.125172895061303	1
Galantamine	Tolterodine	0.369	2.017	Moderate	13 (9/4)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.	#F7B7B7	1.62724763579694	1
Pantoprazole	Itraconazole	0.158	1.61	Moderate	123 (79/44)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F7B9B9	15.3962660925403	1
Nabumetone	Alendronic acid	0.191	7.508	Moderate	75 (67/8)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#EA9B9B	9.38796712959776	1
Lovastatin	Verapamil	0.4	1.11	Major	47 (26/21)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#F9BCBC	5.88312606788126	1
Dihydroergotamine	Propranolol	0.215	7.172	Moderate	27 (24/3)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#EB9C9C	3.37966816665519	1
Erythromycin	Atorvastatin	0.105	-1.272	Major	214 (100/114)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#B4D1E6	26.7869995431189	1
Ciprofloxacin	Iron	0.339	-1.439	Moderate	229 (100/129)		#B2D0E5	28.6645929690385	1
Duloxetine	Nortriptyline	0.335	3.586	Major	20 (16/4)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#F3AFAF	2.50345790122607	0.521020391897414
Lidocaine	Propranolol	0.126	2.51	Moderate	57 (42/15)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#F5B4B4	7.13485501849429	1
Ranolazine	Simvastatin	0.332	-2.406	Major	161 (51/110)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#AECDE3	20.1528361048699	1
Interferon alfa-2b	Theophylline	0.071	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Interferon Alfa-2b. Recombinant.	#B32020	0.125172895061303	1
Rizatriptan	Escitalopram	0.192	4.146	Major	45 (37/8)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#F2ACAC	5.63278027775865	1
Losartan	Lithium cation	0.322	1.289	Moderate	78 (46/32)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#F9BCBC	9.76348581478167	1
Olanzapine	Galantamine	0.477	-2.231	Moderate	21 (7/14)		#AECDE3	2.62863079628737	6.42311591180376e-08
Amitriptyline	Terbutaline	0.191	3.451	Moderate	97 (77/20)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#F3AFAF	12.1417708209464	1
Pioglitazone	Gemfibrozil	0.305	-2.18	Major	65 (22/43)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#AFCEE4	8.13623817898472	1
Citalopram	Almotriptan	0.265	11.953	Major	43 (40/3)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#DF8383	5.38243448763605	1
Zolmitriptan	Fluoxetine	0.244	5.635	Major	51 (44/7)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#EEA4A4	6.38381764812647	1
Ergotamine	Almotriptan	0.244	1.793	Major	15 (10/5)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#F7B9B9	1.87759342591955	0.00351441505101009
Indomethacin	Carvedilol	0.164	-1.7	Moderate	106 (42/64)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#B1CFE5	13.2683268764982	1
Cyclosporine	Amiodarone	0.274	-2.107	Moderate	26 (9/17)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#AFCEE4	3.25449527159389	0.120162116614345
Atomoxetine	Rasagiline	0.152	Inf	Moderate	1 (1/0)	Rasagiline may increase the central neurotoxic activities of Atomoxetine.	#B32020	0.125172895061303	1
Phenobarbital	Acenocoumarol	0.362	-1.649	None	57 (23/34)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#B1CFE5	7.13485501849429	1
Erythromycin	Acenocoumarol	0.094	-1.03	None	100 (52/48)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#B4D1E6	12.5172895061303	1
Rifabutin	Tacrolimus	0.32	1.793	None	3 (2/1)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifabutin.	#F7B9B9	0.37551868518391	1
Spironolactone	Perindopril	0.408	-1.292	Major	41 (19/22)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#B4D1E6	5.13208869751344	1
Paroxetine	Propafenone	0.303	2.758	Moderate	53 (40/13)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#F5B4B4	6.63416343824908	1
Ziprasidone	Donepezil	0.284	Inf	Moderate	3 (3/0)	The metabolism of Donepezil can be decreased when combined with Ziprasidone.	#B32020	0.37551868518391	1
Citalopram	Sumatriptan	0.286	6.275	Major	48 (42/6)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#EDA1A1	6.00829896294256	1
Donepezil	Solifenacin	0.273	-1.115	Moderate	36 (18/18)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Donepezil.	#B4D1E6	4.50622422220692	1
Digoxin	Rabeprazole	0.201	1.001	Moderate	91 (48/43)		#F9BCBC	11.3907334505786	1
Lansoprazole	Itraconazole	0.162	1.444	Moderate	94 (58/36)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F8BABA	11.7662521357625	1
Bisoprolol	Glipizide	0.31	-2.55	Moderate	92 (28/64)	Bisoprolol may increase the hypoglycemic activities of Glipizide.	#ACCCE3	11.5159063456399	1
Biperiden	Rivastigmine	0.233	1.255	Moderate	12 (7/5)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Rivastigmine.	#F9BCBC	1.50207474073564	0.351537892218306
Glimepiride	Pregabalin	0.196	-1.656	None	159 (64/95)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#B1CFE5	19.9024903147472	1
Erythromycin	Diazepam	0.22	2.766	Moderate	143 (108/35)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F5B4B4	17.8997239937664	1
Atenolol	Ergotamine	0.216	1.836	Moderate	64 (43/21)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F7B9B9	8.01106528392342	1
Cyclosporine	Simvastatin	0.356	-1.756	Major	139 (54/85)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#B1CFE5	17.3990324135212	1
Digoxin	Methimazole	0.244	-1.05	Moderate	33 (17/16)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#B4D1E6	4.13070553702301	1
Furosemide	Gentamicin	0.178	-2.008	Major	42 (15/27)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#AFCEE4	5.25726159257474	0.779270297667714
Simvastatin	Fusidic acid	0.058	-1.325	None	140 (64/76)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#B2D0E5	17.5242053085825	1
Lovastatin	Clarithromycin	0.095	2.009	Major	94 (65/29)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#F7B7B7	11.7662521357625	1
Cyclosporine	Ciprofloxacin	0.125	-2.746	Moderate	90 (26/64)		#ACCCE3	11.2655605555173	1
Carbamazepine	Acenocoumarol	0.347	-2.231	None	108 (36/72)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#AECDE3	13.5186726666208	1
Dihydroergotamine	Fluoxetine	0.215	4.226	Major	40 (33/7)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#F2ACAC	5.00691580245214	1
Erythromycin	Lincomycin	0.515	1.494	Moderate	8 (5/3)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#F8BABA	1.00138316049043	0.189712591545038
Indomethacin	Propranolol	0.137	1.261	Moderate	77 (45/32)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#F9BCBC	9.63831291972036	1
Bisoprolol	Ergotamine	0.21	2.637	Moderate	67 (50/17)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F5B4B4	8.38658396910733	1
Naproxen	Acenocoumarol	0.103	-1.493	None	463 (198/265)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	57.9550504133835	1
Prednisone	Warfarin	0.191	-1.536	Moderate	126 (53/73)	Prednisone may increase the anticoagulant activities of Warfarin.	#B2D0E5	15.7717847777242	1
Repaglinide	Gemfibrozil	0.312	-2.554	Major	125 (38/87)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#ACCCE3	15.6466118826629	1
Erythromycin	Fluoxetine	0.132	5.479	Moderate	64 (55/9)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#EFA6A6	8.01106528392342	1
Fludrocortisone	Acetylsalicylic acid	0.316	-1.255	Moderate	51 (24/27)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#B4D1E6	6.38381764812647	1
Metoprolol	Glyburide	0.408	1.103	Moderate	29 (16/13)	Metoprolol may increase the hypoglycemic activities of Glyburide.	#F9BCBC	3.6300139567778	1
Sotalol	Ibuprofen	0.156	-1.134	Moderate	121 (60/61)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#B4D1E6	15.1459203024177	1
Fenofibrate	Fluvastatin	0.425	-2.475	Major	103 (32/71)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#AECDE3	12.8928081913143	1
Fluconazole	Lovastatin	0.107	3.287	Major	42 (33/9)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#F4B1B1	5.25726159257474	1
Terbutaline	Carvedilol	0.082	-1.43	Major	89 (39/50)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#B2D0E5	11.140387660456	1
Omeprazole	Ketoconazole	0.113	-1.429	Moderate	130 (57/73)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#B2D0E5	16.2724763579694	1
Warfarin	Paroxetine	0.308	1.483	Moderate	69 (43/26)	Paroxetine may increase the anticoagulant activities of Warfarin.	#F8BABA	8.63692975922994	1
Gliclazide	Glucosamine	0.162	-1.091	None	182 (92/90)		#B4D1E6	22.7814669011572	1
Almotriptan	Sertraline	0.282	6.275	Major	32 (28/4)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#EDA1A1	4.00553264196171	1
Propranolol	Repaglinide	0.312	-1.659	Moderate	97 (39/58)		#B1CFE5	12.1417708209464	1
Clozapine	Halazepam	0.25	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Clozapine is combined with Halazepam.	#B32020	0.125172895061303	1
Phenytoin	Ciprofloxacin	0.122	-2.519	Moderate	101 (31/70)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#ACCCE3	12.6424624011916	1
Atenolol	Glipizide	0.337	-1.54	Moderate	50 (21/29)	Atenolol may increase the hypoglycemic activities of Glipizide.	#B2D0E5	6.25864475306517	1
Eletriptan	Escitalopram	0.29	Inf	Major	11 (11/0)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#B32020	1.37690184567434	1
Cyclosporine	Tacrolimus	0.13	-2.091	Major	23 (8/15)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#AFCEE4	2.87897658640998	0.0227443203938421
Fluoxetine	Almotriptan	0.238	12.103	Major	29 (27/2)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#DF8383	3.6300139567778	1
Warfarin	Ranitidine	0.234	-1.976	Moderate	97 (35/62)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#AFCEE4	12.1417708209464	1
Fluoxetine	Propafenone	0.297	2.789	Moderate	37 (28/9)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#F5B4B4	4.63139711726823	1
Metoprolol	Fluoxetine	0.385	4.124	Moderate	28 (23/5)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#F2ACAC	3.5048410617165	1
Enalapril	Rifampicin	0.157	-2.459	None	141 (44/97)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#AECDE3	17.6493782036438	1
Dihydroergotamine	Atenolol	0.203	3.387	Moderate	43 (34/9)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F4B1B1	5.38243448763605	1
Clarithromycin	Solifenacin	0.14	1.043	Major	132 (71/61)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#F9BCBC	16.5228221480921	1
Trospium	Tolterodine	0.318	-1.115	Moderate	16 (8/8)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#B4D1E6	2.00276632098085	0.0249971370522878
Erythromycin	Sertraline	0.111	3.394	Moderate	67 (53/14)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#F4B1B1	8.38658396910733	1
Diazepam	Itraconazole	0.21	1.649	Moderate	159 (103/56)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F7B9B9	19.9024903147472	1
Sulfasalazine	Mercaptopurine	0.967	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Paroxetine	Rasagiline	0.342	-1.046	Major	62 (32/30)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#B4D1E6	7.76071949380081	1
Simvastatin	Rifampicin	0.12	-2.012	Major	143 (51/92)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#AFCEE4	17.8997239937664	1
Hydrochlorothiazide	Lithium cation	0.277	1.37	Major	91 (55/36)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#F8BABA	11.3907334505786	1
Repaglinide	Glipizide	0.15	-1.673	None	25 (10/15)	Repaglinide may increase the hypoglycemic activities of Glipizide.	#B1CFE5	3.12932237653259	1
Dihydroergotamine	Sumatriptan	0.258	3.586	Major	10 (8/2)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#F3AFAF	1.25172895061303	1
Phenytoin	Alprazolam	0.29	-1.179	Moderate	72 (35/37)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#B4D1E6	9.01244844441385	1
Carbamazepine	Aripiprazole	0.437	1.025	Moderate	15 (8/7)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#F9BCBC	1.87759342591955	0.516987311762981
Acetaminophen	Isoniazid	0.212	-2.119	Moderate	174 (60/114)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#AFCEE4	21.7800837406668	1
Trazodone	Itraconazole	0.14	3.227	Moderate	46 (36/10)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#F4B1B1	5.75795317281996	1
Digoxin	Methotrexate	0.217	1.793	Moderate	36 (24/12)	Digoxin may decrease the cardiotoxic activities of Methotrexate.	#F7B9B9	4.50622422220692	1
Rivastigmine	Clomipramine	0.212	1.494	Moderate	16 (10/6)		#F8BABA	2.00276632098085	1
Warfarin	Fenofibrate	0.317	-2.583	Major	63 (19/44)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#ACCCE3	7.88589238886212	1
Atenolol	Verapamil	0.303	-1.192	Major	91 (44/47)	Verapamil may increase the hypotensive activities of Atenolol.	#B4D1E6	11.3907334505786	1
Lidocaine	Atenolol	0.111	1.548	Moderate	90 (57/33)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#F8BABA	11.2655605555173	1
Imipramine	Duloxetine	0.285	1.195	Major	28 (16/12)	Duloxetine may increase the serotonergic activities of Imipramine.	#F9BCBC	3.5048410617165	1
Spironolactone	Eprosartan	0.377	-1.369	Major	49 (22/27)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#B2D0E5	6.13347185800387	1
Clonazepam	Itraconazole	0.171	2.185	None	55 (39/16)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F7B7B7	6.88450922837169	1
Digoxin	Prazosin	0.093	Inf	None	3 (3/0)		#B32020	0.37551868518391	1
Zolmitriptan	Dihydroergotamine	0.273	2.241	Major	14 (10/4)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F6B6B6	1.75242053085825	1
Cyclosporine	Primidone	0.113	Inf	Moderate	2 (2/0)	The metabolism of Cyclosporine can be increased when combined with Primidone.	#B32020	0.250345790122607	1
Dihydroergotamine	Almotriptan	0.233	6.275	Major	8 (7/1)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#EDA1A1	1.00138316049043	1
Erythromycin	Methylprednisolone	0.537	1.569	Moderate	44 (28/16)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#F8BABA	5.50760738269735	1
Warfarin	Ibuprofen	0.147	-1.566	Major	238 (99/139)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#B2D0E5	29.7911490245902	1
Cyclosporine	Ezetimibe	0.404	-2.454	Moderate	32 (10/22)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#AECDE3	4.00553264196171	1
Ciprofloxacin	Warfarin	0.145	-2.013	Major	115 (41/74)		#AFCEE4	14.3948829320499	1
Fenofibrate	Ursodeoxycholic acid	0.386	-1.552	None	55 (23/32)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#B2D0E5	6.88450922837169	1
Diltiazem	Propranolol	0.329	1.241	Major	62 (36/26)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#F9BCBC	7.76071949380081	1
Metoprolol	Salbutamol	0.124	-1.359	Moderate	71 (32/39)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#B2D0E5	8.88727554935254	1
Diltiazem	Tacrolimus	0.28	-1.651	Moderate	62 (25/37)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#B1CFE5	7.76071949380081	1
Rosuvastatin	Gemfibrozil	0.28	-2.986	Major	125 (34/91)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#ABCBE2	15.6466118826629	1
Erythromycin	Digoxin	0.121	2.946	Moderate	30 (23/7)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#F5B2B2	3.7551868518391	1
Imipramine	Carbamazepine	0.146	6.275	Moderate	8 (7/1)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#EDA1A1	1.00138316049043	1
Trospium	Solifenacin	0.156	1.614	Moderate	14 (9/5)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#F7B9B9	1.75242053085825	1
Citalopram	Metoprolol	0.289	2.59	Moderate	35 (26/9)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F5B4B4	4.38105132714562	1
Cyclosporine	Sevelamer	0.245	-1.115	Moderate	4 (2/2)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#B4D1E6	0.500691580245214	1
Lovastatin	Carbamazepine	0.328	1.27	None	29 (17/12)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#F9BCBC	3.6300139567778	1
Phenytoin	Sertraline	0.426	-1.283	Moderate	43 (20/23)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#B4D1E6	5.38243448763605	1
Donepezil	Tolterodine	0.435	1.409	Moderate	18 (11/7)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.	#F8BABA	2.25311211110346	1
Leflunomide	Acenocoumarol	0.262	1.281	None	34 (20/14)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	4.25587843208432	1
Doxycycline	Amoxicillin	0.438	-1.53	Moderate	249 (105/144)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#B2D0E5	31.1680508702646	1
Spironolactone	Lisinopril	0.319	-2.024	Major	152 (54/98)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#AFCEE4	19.0262800493181	1
Trimethoprim	Methotrexate	0.178	3.765	Major	26 (21/5)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#F2AEAE	3.25449527159389	1
Clozapine	Donepezil	0.545	Inf	Moderate	1 (1/0)	The metabolism of Donepezil can be decreased when combined with Clozapine.	#B32020	0.125172895061303	1
Nabumetone	Acenocoumarol	0.107	-1.587	None	63 (26/37)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	7.88589238886212	1
Metoprolol	Paroxetine	0.326	1.724	Moderate	38 (25/13)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#F7B9B9	4.75657001232953	1
Clozapine	Flurazepam	0.031	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Flurazepam is combined with Clozapine.	#B32020	0.125172895061303	1
Alendronic acid	Flurbiprofen	0.193	Inf	Moderate	16 (16/0)	The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.	#B32020	2.00276632098085	1
Dihydroergotamine	Bisoprolol	0.198	1.494	Moderate	56 (35/21)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F8BABA	7.00968212343299	1
Fluoxetine	Doxepin	0.192	Inf	Major	8 (8/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#B32020	1.00138316049043	1
Levofloxacin	Iron	0.308	-1.32	Moderate	131 (60/71)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#B2D0E5	16.3976492530307	1
Simvastatin	Ketoconazole	0.077	-1.082	Major	65 (33/32)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#B4D1E6	8.13623817898472	1
Theophylline	Clarithromycin	0.465	-1.169	Moderate	43 (21/22)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#B4D1E6	5.38243448763605	1
Betamethasone	Acetylsalicylic acid	0.066	-1.696	Moderate	126 (50/76)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B1CFE5	15.7717847777242	1
Moclobemide	Clomipramine	0.486	Inf	None	2 (2/0)	Moclobemide may increase the serotonergic activities of Clomipramine.	#B32020	0.250345790122607	1
Trazodone	Ginkgo biloba	0.264	1.733	Moderate	44 (29/15)		#F7B9B9	5.50760738269735	1
Rifabutin	Warfarin	0.333	Inf	None	1 (1/0)	The metabolism of Warfarin can be increased when combined with Rifabutin.	#B32020	0.125172895061303	1
Methotrexate	Sulfamethoxazole	0.19	3.227	Moderate	23 (18/5)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#F4B1B1	2.87897658640998	1
Naproxen	Lithium cation	0.097	1.494	Major	72 (45/27)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#F8BABA	9.01244844441385	1
Warfarin	Methimazole	0.251	1.434	Moderate	13 (8/5)	Methimazole may decrease the anticoagulant activities of Warfarin.	#F8BABA	1.62724763579694	1
Phenytoin	Prednisone	0.174	-1.474	Moderate	65 (28/37)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#B2D0E5	8.13623817898472	1
Allopurinol	Warfarin	0.269	-11.155	Moderate	209 (19/190)	Allopurinol may increase the anticoagulant activities of Warfarin.	#82ACD0	26.1611350678124	1
Diclofenac	Warfarin	0.167	-1.683	Major	143 (57/86)	Diclofenac may increase the anticoagulant activities of Warfarin.	#B1CFE5	17.8997239937664	1
Atenolol	Prazosin	0.331	1.793	Moderate	9 (6/3)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#F7B9B9	1.12655605555173	1
Theophylline	Ciprofloxacin	0.211	-2.617	Major	87 (26/61)		#ACCCE3	10.8900418703334	1
Eletriptan	Paroxetine	0.229	2.914	Major	17 (13/4)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#F5B2B2	2.12793921604216	1
Atorvastatin	Bezafibrate	0.329	-2.543	None	82 (25/57)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#ACCCE3	10.2641773950269	1
Acarbose	Digoxin	0.446	1.345	Moderate	15 (9/6)	The serum concentration of Digoxin can be decreased when it is combined with Acarbose.	#F8BABA	1.87759342591955	1
Fluconazole	Cyclophosphamide	0.69	2.241	None	7 (5/2)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#F6B6B6	0.876210265429124	1
Sertraline	Propafenone	0.321	2.062	Moderate	33 (23/10)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#F7B7B7	4.13070553702301	1
Metoprolol	Clonidine	0.692	Inf	Major	1 (1/0)	Clonidine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.125172895061303	1
Propranolol	Terbutaline	0.12	1.121	Major	63 (35/28)		#F9BCBC	7.88589238886212	1
Ziprasidone	Chlorpromazine	0.046	-1.115	Major	2 (1/1)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#B4D1E6	0.250345790122607	1
Colestipol	Levothyroxine	0.234	2.353	Moderate	29 (21/8)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#F6B6B6	3.6300139567778	1
Flurazepam	Itraconazole	0.175	3.287	None	14 (11/3)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#F4B1B1	1.75242053085825	1
Erythromycin	Levofloxacin	0.554	1.229	Moderate	83 (48/35)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F9BCBC	10.3893502900882	1
Disopyramide	Atenolol	0.293	1.195	Major	7 (4/3)	Disopyramide may increase the bradycardic activities of Atenolol.	#F9BCBC	0.876210265429124	1
Sumatriptan	Escitalopram	0.241	1.992	Major	29 (20/9)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#F7B7B7	3.6300139567778	1
Piroxicam	Alendronic acid	0.135	5.2	None	34 (29/5)	The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.	#F0A7A7	4.25587843208432	1
Rabeprazole	Itraconazole	0.16	1.426	Moderate	57 (35/22)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#F8BABA	7.13485501849429	1
Nortriptyline	Rivastigmine	0.306	Inf	Moderate	3 (3/0)		#B32020	0.37551868518391	1
Fludrocortisone	Phenobarbital	0.198	-1.115	Moderate	4 (2/2)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#B4D1E6	0.500691580245214	1
Hydroxyzine	Donepezil	0.249	4.781	Moderate	19 (16/3)		#F0A9A9	2.37828500616477	1
Dihydroergotamine	Rizatriptan	0.196	3.586	Major	10 (8/2)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#F3AFAF	1.25172895061303	1
Labetalol	Repaglinide	0.183	-1.487	Moderate	7 (3/4)		#B2D0E5	0.876210265429124	1
Galantamine	Paroxetine	0.337	1.345	Moderate	25 (15/10)	The metabolism of Galantamine can be decreased when combined with Paroxetine.	#F8BABA	3.12932237653259	1
Sucralfate	Ibandronate	0.191	Inf	Moderate	20 (20/0)		#B32020	2.50345790122607	1
Ergotamine	Clarithromycin	0.173	3.714	Major	36 (29/7)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#F3AFAF	4.50622422220692	1
Duloxetine	Rasagiline	0.381	-1.041	Major	29 (15/14)	Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.	#B4D1E6	3.6300139567778	1
Chlorpropamide	Acetylsalicylic acid	0.33	1.569	None	11 (7/4)	Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.	#F8BABA	1.37690184567434	1
Cyclosporine	Pravastatin	0.441	-4.183	Major	57 (12/45)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#A5C6DF	7.13485501849429	0.00821512560716749
Fluoxetine	Sumatriptan	0.319	2.465	Major	30 (22/8)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#F6B6B6	3.7551868518391	1
Fluoxetine	Warfarin	0.289	1.494	Moderate	40 (25/15)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F8BABA	5.00691580245214	1
Metoprolol	Escitalopram	0.343	-1.115	Minor	30 (15/15)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#B4D1E6	3.7551868518391	1
Cyclosporine	Sulfasalazine	0.186	Inf	Major	2 (2/0)	Sulfasalazine may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.250345790122607	1
Haloperidol	Propranolol	0.322	-1.562	Moderate	36 (15/21)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#B2D0E5	4.50622422220692	1
Levofloxacin	Methotrimeprazine	0.192	-1.47	Moderate	51 (22/29)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#B2D0E5	6.38381764812647	1
Celecoxib	Acenocoumarol	0.152	-1.263	None	145 (68/77)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	18.150069783889	1
Warfarin	Leflunomide	0.17	2.689	Moderate	8 (6/2)	Leflunomide may increase the anticoagulant activities of Warfarin.	#F5B4B4	1.00138316049043	1
Salbutamol	Nadolol	0.2	-1.115	Major	48 (24/24)		#B4D1E6	6.00829896294256	1
Itraconazole	Budesonide	0.215	-1.115	Major	140 (70/70)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#B4D1E6	17.5242053085825	1
Terbutaline	Clomipramine	0.099	1.644	Moderate	34 (22/12)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#F7B9B9	4.25587843208432	1
Trospium	Risperidone	0.213	4.482	Moderate	6 (5/1)		#F1ABAB	0.751037370367821	1
Acenocoumarol	Cholestyramine	0.149	-1.227	None	42 (20/22)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	5.25726159257474	1
Diltiazem	Midazolam	0.372	-1.115	Moderate	20 (10/10)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#B4D1E6	2.50345790122607	1
Clozapine	Lamotrigine	0.259	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#B32020	0.125172895061303	1
Metoprolol	Formoterol	0.124	-1.301	Moderate	39 (18/21)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#B4D1E6	4.88174290739083	1
Doxycycline	Rifabutin	1	Inf	Moderate	1 (1/0)	The metabolism of Rifabutin can be decreased when combined with Doxycycline.	#B32020	0.125172895061303	1
Ciprofloxacin	Rasagiline	0.101	-2.856	Major	89 (25/64)		#ABCBE2	11.140387660456	1
Bisoprolol	Epinephrine	0.123	-1.358	Moderate	51 (23/28)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B2D0E5	6.38381764812647	1
Atorvastatin	Josamycin	0.086	-1.162	None	49 (24/25)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#B4D1E6	6.13347185800387	1
Eletriptan	Venlafaxine	0.176	7.172	Major	9 (8/1)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#EB9C9C	1.12655605555173	1
Metoclopramide	Levodopa	0.1	1.025	Moderate	60 (32/28)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#F9BCBC	7.51037370367821	1
Phenylephrine	Rasagiline	0.077	Inf	Moderate	1 (1/0)	Rasagiline may increase the hypertensive activities of Phenylephrine.	#B32020	0.125172895061303	1
Eletriptan	Sertraline	0.254	Inf	Major	9 (9/0)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#B32020	1.12655605555173	1
Flutamide	Acenocoumarol	0.487	-2.231	None	6 (2/4)		#AECDE3	0.751037370367821	1
Warfarin	Fluvastatin	0.228	-1.521	Minor	26 (11/15)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#B2D0E5	3.25449527159389	1
Fluoxetine	Rasagiline	0.199	1.467	Major	29 (18/11)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#F8BABA	3.6300139567778	1
Lovastatin	Itraconazole	0.087	1.63	Major	31 (20/11)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#F7B9B9	3.88035974690041	1
Phenytoin	Amiodarone	0.397	-1.912	Moderate	19 (7/12)	The serum concentration of Phenytoin can be increased when it is combined with Amiodarone.	#AFCEE4	2.37828500616477	1
Clomipramine	Rasagiline	0.35	-1.255	Major	17 (8/9)	Rasagiline may increase the serotonergic activities of Clomipramine.	#B4D1E6	2.12793921604216	1
Folic acid	Primidone	0.181	1.345	Moderate	10 (6/4)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#F8BABA	1.25172895061303	1
Metoprolol	Salmeterol	0.239	-1.275	Moderate	30 (14/16)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#B4D1E6	3.7551868518391	1
Sotalol	Levofloxacin	0.08	-1.195	Major	29 (14/15)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	3.6300139567778	1
Imipramine	Salbutamol	0.187	1.956	Moderate	35 (24/11)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#F7B7B7	4.38105132714562	1
Dextromethorphan	Memantine	0.085	2.241	Minor	21 (15/6)	The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Memantine.	#F6B6B6	2.62863079628737	1
Theophylline	Lithium cation	0.173	-1.115	Moderate	8 (4/4)	The serum concentration of Lithium can be decreased when it is combined with Theophylline.	#B4D1E6	1.00138316049043	1
Fluvastatin	Gemfibrozil	0.337	-3.081	Major	79 (21/58)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#ABCBE2	9.88865870984297	1
Esomeprazole	Itraconazole	0.216	1.644	Moderate	51 (33/18)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#F7B9B9	6.38381764812647	1
Rifampicin	Atorvastatin	0.148	-3.625	Major	85 (20/65)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#A8C8E1	10.6396960802108	1
Alprazolam	Cimetidine	0.108	1.025	Moderate	15 (8/7)		#F9BCBC	1.87759342591955	1
Repaglinide	Clarithromycin	0.092	-1.634	Moderate	106 (43/63)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#B1CFE5	13.2683268764982	1
Cyclosporine	Azithromycin	0.096	-1.82	Moderate	50 (19/31)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#B1CFE5	6.25864475306517	1
Dihydroergotamine	Nadolol	0.107	Inf	Moderate	4 (4/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.500691580245214	1
Cyclosporine	Metoclopramide	0.171	-2.231	Moderate	42 (14/28)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#AECDE3	5.25726159257474	1
Dihydroergotamine	Clarithromycin	0.237	3.945	Major	27 (22/5)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#F2AEAE	3.37966816665519	1
Glipizide	Carvedilol	0.243	-4.143	Moderate	33 (7/26)	Carvedilol may increase the hypoglycemic activities of Glipizide.	#A5C6DF	4.13070553702301	1
Cyclosporine	Ticlopidine	0.05	Inf	Moderate	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Ticlopidine.	#B32020	0.125172895061303	1
Cyclosporine	Ibuprofen	0.147	-2.231	Moderate	114 (38/76)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#AECDE3	14.2697100369886	1
Phenytoin	Cimetidine	0.5	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Cimetidine is combined with Phenytoin.	#B32020	0.125172895061303	1
Pyridostigmine	Fludrocortisone	0.49	-4.462	Moderate	5 (1/4)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#A3C5DF	0.625864475306517	0.00672274463487866
Methotrexate	Cloxacillin	0.071	1.793	Major	33 (22/11)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F7B9B9	4.13070553702301	1
Spironolactone	Quinapril	0.336	-2.637	Major	37 (11/26)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#ACCCE3	4.63139711726823	1
Fluconazole	Flurazepam	0.154	4.482	None	12 (10/2)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#F1ABAB	1.50207474073564	1
Repaglinide	Glucosamine	0.198	-1.052	None	68 (35/33)		#B4D1E6	8.51175686416863	1
Digoxin	Indapamide	0.263	-1.503	Moderate	54 (23/31)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#B2D0E5	6.75933633331038	1
Tenoxicam	Alendronic acid	0.22	12.551	None	15 (14/1)	The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.	#DE8080	1.87759342591955	1
Norfloxacin	Iron	0.324	2.809	None	62 (47/15)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#F5B4B4	7.76071949380081	1
Prednisone	Rifampicin	0.327	-1.983	Moderate	50 (18/32)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#AFCEE4	6.25864475306517	1
Piroxicam	Methotrexate	0.316	1.255	Major	12 (7/5)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#F9BCBC	1.50207474073564	1
Fluconazole	Midazolam	0.324	2.017	Major	13 (9/4)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#F7B7B7	1.62724763579694	1
Torasemide	Gentamicin	0.112	-1.115	Major	14 (7/7)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#B4D1E6	1.75242053085825	1
Itraconazole	Solifenacin	0.157	1.16	Major	39 (22/17)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#F9BCBC	4.88174290739083	1
Galantamine	Solifenacin	0.327	-1.301	Moderate	13 (6/7)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Galantamine.	#B4D1E6	1.62724763579694	1
Donepezil	Methotrimeprazine	0.2	-1.115	Moderate	8 (4/4)	The metabolism of Donepezil can be decreased when combined with Methotrimeprazine.	#B4D1E6	1.00138316049043	1
Amitriptyline	Rasagiline	0.221	-1.813	Major	42 (16/26)	Rasagiline may increase the serotonergic activities of Amitriptyline.	#B1CFE5	5.25726159257474	1
Verapamil	Carvedilol	0.322	-1.413	Major	34 (15/19)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#B2D0E5	4.25587843208432	1
Hydrocortisone	Phenobarbital	0.293	-1.004	Moderate	19 (10/9)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#B4D1E6	2.37828500616477	1
Phenytoin	Levodopa	0.498	-2.9	Moderate	18 (5/13)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#ABCBE2	2.25311211110346	1
Chlorthalidone	Digoxin	0.338	-1.603	Moderate	39 (16/23)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#B2D0E5	4.88174290739083	1
Sucralfate	Ciprofloxacin	0.387	-1.622	Moderate	81 (33/48)		#B1CFE5	10.1390044999656	1
Ibandronate	Iron	0.219	11.654	Moderate	28 (26/2)		#E08585	3.5048410617165	1
Gemfibrozil	Ursodeoxycholic acid	0.366	-1.255	None	34 (16/18)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#B4D1E6	4.25587843208432	1
Fluvoxamine	Rizatriptan	0.293	4.482	Major	6 (5/1)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#F1ABAB	0.751037370367821	1
Salbutamol	Rasagiline	0.159	-2.632	Moderate	84 (25/59)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#ACCCE3	10.5145231851495	1
Pravastatin	Colchicine	0.199	-6.102	Major	110 (17/93)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#9CBFDB	13.7690184567434	1
Phenytoin	Fluoxetine	0.358	-1.753	Moderate	36 (14/22)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#B1CFE5	4.50622422220692	1
Citalopram	Eletriptan	0.315	8.965	Major	11 (10/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#E69393	1.37690184567434	1
Fluvoxamine	Naratriptan	0.576	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Naratriptan.	#B32020	0.125172895061303	1
Indomethacin	Acenocoumarol	0.164	-2.677	None	119 (35/84)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#ACCCE3	14.8955745122951	1
Donepezil	Oxybutynin	0.184	1.195	Moderate	7 (4/3)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.	#F9BCBC	0.876210265429124	1
Clozapine	Sertraline	0.302	2.689	Major	4 (3/1)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#F5B4B4	0.500691580245214	1
Fluconazole	Fluvastatin	0.111	1.467	Moderate	29 (18/11)	The serum concentration of Fluvastatin can be increased when it is combined with Fluconazole.	#F8BABA	3.6300139567778	1
Mefenamic acid	Acenocoumarol	0.108	1.345	None	5 (3/2)	Mefenamic acid may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	0.625864475306517	1
Venlafaxine	Naratriptan	0.248	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.	#B32020	0.500691580245214	1
Carbamazepine	Verapamil	0.208	-1.239	Major	19 (9/10)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#B4D1E6	2.37828500616477	1
Doxycycline	Methotrexate	0.163	2.465	Moderate	15 (11/4)		#F6B6B6	1.87759342591955	1
Cyclosporine	Fluvastatin	0.386	-1.562	Moderate	12 (5/7)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#B2D0E5	1.50207474073564	1
Dextropropoxyphene	Acenocoumarol	0.07	2.689	None	4 (3/1)		#F5B4B4	0.500691580245214	1
Fluconazole	Tacrolimus	0.414	-1.444	Major	39 (17/22)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#B2D0E5	4.88174290739083	1
Moxifloxacin	Amiodarone	0.173	-3.17	Major	73 (19/54)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#A9C9E1	9.13762133947515	1
Venlafaxine	Propafenone	0.376	2.689	Moderate	20 (15/5)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#F5B4B4	2.50345790122607	1
Ranitidine	Itraconazole	0.226	1.121	Moderate	63 (35/28)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F9BCBC	7.88589238886212	1
Tobramycin	Furosemide	0.157	-1.115	Major	8 (4/4)	The serum concentration of Tobramycin can be increased when it is combined with Furosemide.	#B4D1E6	1.00138316049043	1
Fluvoxamine	Theophylline	0.388	2.689	Major	4 (3/1)	The metabolism of Theophylline can be decreased when combined with Fluvoxamine.	#F5B4B4	0.500691580245214	1
Erythromycin	Verapamil	0.101	2.152	Major	17 (12/5)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#F7B7B7	2.12793921604216	1
Warfarin	Norfloxacin	0.114	1.586	Major	36 (23/13)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#F8BABA	4.50622422220692	1
Rosiglitazone	Gemfibrozil	0.341	-3.506	Moderate	29 (7/22)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#A8C8E1	3.6300139567778	1
Alprazolam	Josamycin	0.064	17.93	None	21 (20/1)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#D16363	2.62863079628737	1
Lovastatin	Warfarin	0.309	2.241	Moderate	14 (10/4)	The metabolism of Warfarin can be decreased when combined with Lovastatin.	#F6B6B6	1.75242053085825	1
Lidocaine	Carvedilol	0.13	-1.921	Moderate	49 (18/31)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#AFCEE4	6.13347185800387	1
Pravastatin	Bezafibrate	0.242	-1.562	None	24 (10/14)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#B2D0E5	3.00414948147128	1
Ketoconazole	Atorvastatin	0.09	-1.459	Major	30 (13/17)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#B2D0E5	3.7551868518391	1
Amitriptyline	Donepezil	0.229	1.921	Moderate	22 (15/7)		#F7B7B7	2.75380369134868	1
Ropinirole	Ciprofloxacin	0.113	-1.115	Moderate	36 (18/18)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#B4D1E6	4.50622422220692	1
Galantamine	Clomipramine	0.385	1.195	Moderate	7 (4/3)	The metabolism of Galantamine can be decreased when combined with Clomipramine.	#F9BCBC	0.876210265429124	1
Cyclosporine	Norfloxacin	0.147	2.152	Moderate	17 (12/5)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#F7B7B7	2.12793921604216	1
Paroxetine	Frovatriptan	0.412	3.138	None	9 (7/2)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#F4B1B1	1.12655605555173	1
Metoprolol	Indomethacin	0.154	1.025	Moderate	15 (8/7)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#F9BCBC	1.87759342591955	1
Phenytoin	Warfarin	0.33	-1.115	Moderate	8 (4/4)	Phenytoin may increase the anticoagulant activities of Warfarin.	#B4D1E6	1.00138316049043	1
Verapamil	Primidone	0.177	1.345	Moderate	5 (3/2)	The metabolism of Verapamil can be increased when combined with Primidone.	#F8BABA	0.625864475306517	1
Trospium	Zuclopenthixol	0.045	Inf	None	1 (1/0)		#B32020	0.125172895061303	1
Warfarin	Levofloxacin	0.159	-2.383	Major	69 (22/47)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#AECDE3	8.63692975922994	1
Danazol	Acenocoumarol	0.371	Inf	None	2 (2/0)	Danazol may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.250345790122607	1
Metronidazole	Acenocoumarol	0.093	-2.442	None	118 (37/81)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#AECDE3	14.7704016172338	1
Fentanyl	Rifampicin	0.318	-2.868	Major	25 (7/18)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#ABCBE2	3.12932237653259	1
Atorvastatin	Fusidic acid	0.102	-1.937	None	52 (19/33)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#AFCEE4	6.50899054318778	1
Trospium	Quetiapine	0.369	-1.339	Moderate	11 (5/6)		#B2D0E5	1.37690184567434	1
Triamcinolone	Phenobarbital	0.035	1.255	Moderate	12 (7/5)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#F9BCBC	1.50207474073564	1
Duloxetine	Propafenone	0.266	2.689	Moderate	16 (12/4)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#F5B4B4	2.00276632098085	1
Lovastatin	Gemfibrozil	0.304	-2.172	Major	56 (19/37)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#AFCEE4	7.00968212343299	1
Atenolol	Chlorpropamide	0.427	Inf	Moderate	3 (3/0)	Atenolol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.37551868518391	1
Diltiazem	Rifampicin	0.198	-1.859	Major	16 (6/10)	The serum concentration of Diltiazem can be decreased when it is combined with Rifampicin.	#B1CFE5	2.00276632098085	1
Losartan	Rifampicin	0.098	-2.082	Moderate	43 (15/28)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#AFCEE4	5.38243448763605	1
Eletriptan	Dihydroergotamine	0.161	Inf	Major	2 (2/0)	The serum concentration of Eletriptan can be increased when it is combined with Dihydroergotamine.	#B32020	0.250345790122607	1
Labetalol	Ibuprofen	0.097	1.295	Moderate	22 (13/9)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#F9BCBC	2.75380369134868	1
Warfarin	Phenobarbital	0.223	-1.115	Major	8 (4/4)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#B4D1E6	1.00138316049043	1
Methotrexate	Phenylbutazone	0.201	-6.693	Major	7 (1/6)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#99BDDA	0.876210265429124	0.000233957239692132
Clozapine	Clonazepam	0.315	-2.231	Moderate	6 (2/4)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#AECDE3	0.751037370367821	0.422324131120871
Prednisone	Itraconazole	0.391	-1.068	Moderate	92 (47/45)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#B4D1E6	11.5159063456399	1
Imipramine	Rasagiline	0.362	Inf	Major	3 (3/0)	Rasagiline may increase the serotonergic activities of Imipramine.	#B32020	0.37551868518391	1
Ergotamine	Carvedilol	0.287	3.287	Moderate	14 (11/3)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F4B1B1	1.75242053085825	1
Ciprofloxacin	Tizanidine	0.261	-1.115	Major	62 (31/31)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#B4D1E6	7.76071949380081	1
Tolterodine	Itraconazole	0.223	1.921	Moderate	22 (15/7)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#F7B7B7	2.75380369134868	1
Metoprolol	Repaglinide	0.347	-1.434	Moderate	16 (7/9)		#B2D0E5	2.00276632098085	1
Ramipril	Tizanidine	0.111	-1.177	Major	37 (18/19)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#B4D1E6	4.63139711726823	1
Cimetidine	Flurazepam	0.05	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Methylprednisolone	Rifampicin	0.109	1.076	Moderate	11 (6/5)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#F9BCBC	1.37690184567434	1
Citalopram	Josamycin	0.065	6.724	None	17 (15/2)		#EC9F9F	2.12793921604216	1
Clarithromycin	Quetiapine	0.147	1.385	Major	56 (34/22)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F8BABA	7.00968212343299	1
Prazosin	Carvedilol	0.311	1.793	Moderate	3 (2/1)	Prazosin may increase the antihypertensive activities of Carvedilol.	#F7B9B9	0.37551868518391	1
Atomoxetine	Fluoxetine	0.129	Inf	Major	2 (2/0)	The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.	#B32020	0.250345790122607	1
Citalopram	Pimozide	0.439	1.494	Major	8 (5/3)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#F8BABA	1.00138316049043	1
Sucralfate	Levofloxacin	0.423	-1.208	Moderate	50 (24/26)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#B4D1E6	6.25864475306517	1
Digoxin	Clarithromycin	0.136	-1.583	Major	75 (31/44)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#B2D0E5	9.38796712959776	1
Tacrolimus	Metronidazole	0.229	-1.115	Moderate	36 (18/18)		#B4D1E6	4.50622422220692	1
Carbamazepine	Oxybutynin	0.128	-1.339	None	11 (5/6)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#B2D0E5	1.37690184567434	1
Amitriptyline	Galantamine	0.421	7.172	Moderate	9 (8/1)		#EB9C9C	1.12655605555173	1
Cyclosporine	Phenobarbital	0.275	-2.231	Moderate	6 (2/4)	The metabolism of Cyclosporine can be increased when combined with Phenobarbital.	#AECDE3	0.751037370367821	1
Fluvoxamine	Rasagiline	0.166	Inf	Major	3 (3/0)	The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.	#B32020	0.37551868518391	1
Fluconazole	Tolterodine	0.208	-1.255	Moderate	34 (16/18)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#B4D1E6	4.25587843208432	1
Gentamicin	Cefonicid	0.5	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Lovastatin	Rifampicin	0.24	Inf	Major	5 (5/0)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#B32020	0.625864475306517	1
Ampicillin	Acenocoumarol	0.048	-1.339	None	11 (5/6)	Ampicillin may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	1.37690184567434	1
Amitriptyline	Rivastigmine	0.23	-1.301	Moderate	26 (12/14)		#B4D1E6	3.25449527159389	1
Erythromycin	Moxifloxacin	0.522	1.793	Major	27 (18/9)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F7B9B9	3.37966816665519	1
Metoprolol	Gliclazide	0.34	-2.637	None	37 (11/26)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	4.63139711726823	1
Lisinopril	Lithium cation	0.286	-1.19	Moderate	31 (15/16)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#B4D1E6	3.88035974690041	1
Diazepam	Rifampicin	0.164	1.614	Minor	28 (18/10)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#F7B9B9	3.5048410617165	1
Eletriptan	Clarithromycin	0.047	Inf	Major	7 (7/0)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#B32020	0.876210265429124	1
Dihydroergotamine	Telithromycin	0.053	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Telithromycin.	#B32020	0.125172895061303	1
Glimepiride	Glucosamine	0.252	1.025	None	45 (24/21)		#F9BCBC	5.63278027775865	1
Clozapine	Ketazolam	0.65	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Clozapine is combined with Ketazolam.	#B32020	0.125172895061303	1
Ziprasidone	Carbamazepine	0.214	Inf	Minor	2 (2/0)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#B32020	0.250345790122607	1
Carbamazepine	Clarithromycin	0.14	-1.009	Major	40 (21/19)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#B4D1E6	5.00691580245214	1
Alendronic acid	Ketoprofen	0.153	14.344	Moderate	17 (16/1)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#DA7676	2.12793921604216	1
Lovastatin	Bezafibrate	0.373	4.482	None	6 (5/1)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Lovastatin.	#F1ABAB	0.751037370367821	1
Lithium cation	Etoricoxib	0.183	1.457	None	21 (13/8)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#F8BABA	2.62863079628737	1
Digoxin	Cholestyramine	0.163	1.025	Moderate	15 (8/7)	Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	1.87759342591955	1
Hydrocortisone	Cholestyramine	0.246	-1.115	Moderate	22 (11/11)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	2.75380369134868	1
Verapamil	Colchicine	0.232	-4.462	Major	30 (6/24)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#A3C5DF	3.7551868518391	1
Atenolol	Piroxicam	0.134	1.457	Moderate	21 (13/8)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#F8BABA	2.62863079628737	1
Lovastatin	Fenofibrate	0.315	-1.444	Major	39 (17/22)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#B2D0E5	4.88174290739083	1
Chlorpromazine	Propranolol	0.254	1.793	Moderate	6 (4/2)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#F7B9B9	0.751037370367821	1
Ramipril	Lithium cation	0.264	-2.028	Moderate	31 (11/20)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#AFCEE4	3.88035974690041	1
Doxycycline	Warfarin	0.095	1.345	Moderate	10 (6/4)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#F8BABA	1.25172895061303	1
Ticlopidine	Theophylline	0.167	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Ticlopidine.	#B32020	0.125172895061303	1
Glyburide	Nadolol	0.225	1.046	Moderate	13 (7/6)	Nadolol may increase the hypoglycemic activities of Glyburide.	#F9BCBC	1.62724763579694	1
Disopyramide	Omeprazole	0.494	-1.239	None	19 (9/10)		#B4D1E6	2.37828500616477	1
Hydroxyzine	Galantamine	0.149	5.379	Moderate	7 (6/1)		#EFA6A6	0.876210265429124	1
Warfarin	Azathioprine	0.407	-1.115	Moderate	8 (4/4)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#B4D1E6	1.00138316049043	1
Verapamil	Eplerenone	0.398	-3.625	Moderate	17 (4/13)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#A8C8E1	2.12793921604216	1
Carbamazepine	Dextropropoxyphene	0.25	Inf	None	1 (1/0)	The metabolism of Dextropropoxyphene can be increased when combined with Carbamazepine.	#B32020	0.125172895061303	1
Haloperidol	Itraconazole	0.151	3.586	Moderate	10 (8/2)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#F3AFAF	1.25172895061303	1
Propranolol	Propafenone	0.251	1.614	Moderate	14 (9/5)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#F7B9B9	1.75242053085825	1
Fluconazole	Celecoxib	0.245	2.445	Moderate	41 (30/11)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F6B6B6	5.13208869751344	1
Cyclosporine	Fluconazole	0.294	-4.016	Moderate	23 (5/18)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#A6C7E0	2.87897658640998	1
Erythromycin	Repaglinide	0.095	-1.275	Moderate	30 (14/16)	The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.	#B4D1E6	3.7551868518391	1
Metoprolol	Terbutaline	0.078	1.255	Moderate	12 (7/5)	Metoprolol may decrease the bronchodilatory activities of Terbutaline.	#F9BCBC	1.50207474073564	1
Irbesartan	Lithium cation	0.288	1.614	Moderate	14 (9/5)	The serum concentration of Lithium can be increased when it is combined with Irbesartan.	#F7B9B9	1.75242053085825	1
Fluvastatin	Colchicine	0.294	-3.984	Major	32 (7/25)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#A6C7E0	4.00553264196171	1
Erythromycin	Lovastatin	0.109	1.059	Major	24 (13/11)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#F9BCBC	3.00414948147128	1
Phenytoin	Felodipine	0.58	1.793	Major	3 (2/1)	The metabolism of Felodipine can be increased when combined with Phenytoin.	#F7B9B9	0.37551868518391	1
Lorazepam	Clozapine	0.312	-1.115	Major	10 (5/5)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#B4D1E6	1.25172895061303	1
Ethinylestradiol	Cloxacillin	1	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Nortriptyline	Carbamazepine	0.369	1.345	Moderate	5 (3/2)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#F8BABA	0.625864475306517	1
Fluvoxamine	Carbamazepine	0.286	-2.789	Moderate	14 (4/10)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#ACCCE3	1.75242053085825	1
Salbutamol	Doxepin	0.117	3.138	Moderate	9 (7/2)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#F4B1B1	1.12655605555173	1
Fluvoxamine	Frovatriptan	0.1	Inf	Major	1 (1/0)	The metabolism of Frovatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.125172895061303	1
Prazosin	Propranolol	0.348	-1.673	Moderate	5 (2/3)	Propranolol may increase the orthostatic hypotensive activities of Prazosin.	#B1CFE5	0.625864475306517	1
Indomethacin	Labetalol	0.065	Inf	Moderate	2 (2/0)	Indomethacin may decrease the antihypertensive activities of Labetalol.	#B32020	0.250345790122607	1
Nabumetone	Warfarin	0.384	4.482	Major	6 (5/1)	Nabumetone may increase the anticoagulant activities of Warfarin.	#F1ABAB	0.751037370367821	1
Minocycline	Amoxicillin	0.355	-1.464	Moderate	74 (32/42)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#B2D0E5	9.26279423453645	1
Azithromycin	Warfarin	0.089	-1.919	Moderate	68 (25/43)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#AFCEE4	8.51175686416863	1
Sotalol	Formoterol	0.203	-1.487	Major	21 (9/12)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#B2D0E5	2.62863079628737	1
Venlafaxine	Frovatriptan	0.195	3.586	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#F3AFAF	0.625864475306517	1
Dexamethasone	Acenocoumarol	0.205	-2.328	None	71 (23/48)		#AECDE3	8.88727554935254	1
Atenolol	Insulin glulisine	0.239	-2.324	Moderate	37 (12/25)		#AECDE3	4.63139711726823	1
Colestipol	Raloxifene	0.402	4.482	Moderate	6 (5/1)	Colestipol can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F1ABAB	0.751037370367821	1
Amiodarone	Clarithromycin	0.158	-1.72	Major	61 (24/37)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#B1CFE5	7.63554659873951	1
Dihydroergotamine	Carvedilol	0.277	1.434	Moderate	13 (8/5)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F8BABA	1.62724763579694	1
Fentanyl	Itraconazole	0.205	1.089	Major	31 (17/14)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#F9BCBC	3.88035974690041	1
Carbamazepine	Metronidazole	0.123	-1.301	Moderate	26 (12/14)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#B4D1E6	3.25449527159389	1
Cyclosporine	Digoxin	0.344	-1.673	Moderate	10 (4/6)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#B1CFE5	1.25172895061303	1
Diazepam	Josamycin	0.132	4.034	None	22 (18/4)		#F2ACAC	2.75380369134868	1
Carbamazepine	Itraconazole	0.084	2.017	Moderate	13 (9/4)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#F7B7B7	1.62724763579694	1
Moxifloxacin	Warfarin	0.199	-2.342	Major	31 (10/21)		#AECDE3	3.88035974690041	1
Cyclosporine	Fluoxetine	0.331	1.195	Moderate	14 (8/6)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#F9BCBC	1.75242053085825	1
Phenytoin	Hydrocortisone	0.21	-2.709	Moderate	24 (7/17)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#ACCCE3	3.00414948147128	1
Metoprolol	Diltiazem	0.311	-1.487	Major	14 (6/8)	The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.	#B2D0E5	1.75242053085825	1
Prednisone	Estriol	0.292	Inf	None	33 (33/0)	The serum concentration of Prednisone can be increased when it is combined with Estriol.	#B32020	4.13070553702301	1
Fluconazole	Carbamazepine	0.079	1.494	Moderate	16 (10/6)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F8BABA	2.00276632098085	1
Phenytoin	Clarithromycin	0.089	-1.42	Moderate	25 (11/14)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#B2D0E5	3.12932237653259	1
Gentamicin	Cefuroxime	0.429	-2.008	Moderate	14 (5/9)		#AFCEE4	1.75242053085825	1
Rifampicin	Clarithromycin	0.461	-1.859	Moderate	24 (9/15)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#B1CFE5	3.00414948147128	1
Atenolol	Epinephrine	0.269	1.345	Moderate	20 (12/8)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F8BABA	2.50345790122607	1
Verapamil	Phenobarbital	0.464	-1.115	Moderate	8 (4/4)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#B4D1E6	1.00138316049043	1
Fluvoxamine	Duloxetine	0.296	1.025	Major	15 (8/7)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#F9BCBC	1.87759342591955	1
Trazodone	Warfarin	0.358	-1.45	Minor	23 (10/13)	Trazodone may decrease the anticoagulant activities of Warfarin.	#B2D0E5	2.87897658640998	1
Fluconazole	Rifabutin	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Rifabutin can be increased when it is combined with Fluconazole.	#B32020	0.125172895061303	1
Fluconazole	Haloperidol	0.566	-4.044	Major	37 (8/29)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#A5C6DF	4.63139711726823	1
Epinephrine	Carvedilol	0.067	-1.487	Major	14 (6/8)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B2D0E5	1.75242053085825	1
Alprazolam	Ketoconazole	0.098	-1.227	Major	21 (10/11)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#B4D1E6	2.62863079628737	1
Paroxetine	Pimozide	0.345	3.586	Major	5 (4/1)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#F3AFAF	0.625864475306517	1
Bisoprolol	Rifampicin	0.196	-3.955	Moderate	50 (11/39)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#A6C7E0	6.25864475306517	1
Lovastatin	Tacrolimus	0.192	-1.014	Moderate	21 (11/10)	The serum concentration of Lovastatin can be increased when it is combined with Tacrolimus.	#B4D1E6	2.62863079628737	1
Amitriptyline	Pseudoephedrine	0.181	1.718	None	35 (23/12)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#F7B9B9	4.38105132714562	1
Fluconazole	Acenocoumarol	0.096	-3.253	None	94 (24/70)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#A9C9E1	11.7662521357625	1
Cyclosporine	Verapamil	0.354	-2.975	Moderate	11 (3/8)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#ABCBE2	1.37690184567434	1
Allopurinol	Mercaptopurine	0.18	-1.115	Major	4 (2/2)	The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.	#B4D1E6	0.500691580245214	1
Colestipol	Fluvastatin	0.18	-1.115	Moderate	6 (3/3)	Colestipol can cause a decrease in the absorption of Fluvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.751037370367821	1
Cyproheptadine	Fluoxetine	0.464	1.793	Moderate	3 (2/1)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#F7B9B9	0.37551868518391	1
Fluvoxamine	Acenocoumarol	0.369	-1.239	None	19 (9/10)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#B4D1E6	2.37828500616477	1
Acenocoumarol	Etoricoxib	0.104	-1.526	None	90 (38/52)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	11.2655605555173	1
Ranolazine	Amiodarone	0.376	-6.693	Major	21 (3/18)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#99BDDA	2.62863079628737	1
Itraconazole	Clarithromycin	0.483	2.331	Moderate	36 (26/10)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#F6B6B6	4.50622422220692	1
Doxycycline	Cloxacillin	0.714	1.233	Moderate	19 (11/8)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#F9BCBC	2.37828500616477	1
Spironolactone	Benazepril	0.424	-2.231	Major	6 (2/4)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#AECDE3	0.751037370367821	1
Bumetanide	Ibuprofen	0.264	2.241	Moderate	14 (10/4)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#F6B6B6	1.75242053085825	1
Fluoxetine	Josamycin	0.149	2.017	None	13 (9/4)		#F7B7B7	1.62724763579694	1
Spironolactone	Fosinopril	0.47	1.121	Major	9 (5/4)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.	#F9BCBC	1.12655605555173	1
Prednisone	Ethinylestradiol	0.269	Inf	Moderate	2 (2/0)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.250345790122607	1
Verapamil	Midazolam	0.349	-1.952	Moderate	11 (4/7)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#AFCEE4	1.37690184567434	1
Metoprolol	Sertraline	0.267	-1.115	Moderate	20 (10/10)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#B4D1E6	2.50345790122607	1
Trospium	Cetirizine	0.15	2.241	None	14 (10/4)		#F6B6B6	1.75242053085825	1
Methylergometrine	Nitroglycerin	1	-1.115	Moderate	2 (1/1)	The bioavailability of Methylergometrine can be increased when combined with Nitroglycerin.	#B4D1E6	0.250345790122607	1
Midazolam	Clarithromycin	0.101	3.287	Moderate	14 (11/3)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#F4B1B1	1.75242053085825	1
Nifedipine	Phenobarbital	0.375	-1.115	Major	8 (4/4)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#B4D1E6	1.00138316049043	1
Methylphenidate	Carbamazepine	0.104	-1.115	None	6 (3/3)		#B4D1E6	0.751037370367821	1
Fluoxetine	Frovatriptan	0.433	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#B32020	0.500691580245214	1
Digoxin	Hydroxychloroquine	0.232	1.255	Moderate	12 (7/5)	The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.	#F9BCBC	1.50207474073564	1
Itraconazole	Phenobarbital	0.063	1.494	Moderate	8 (5/3)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#F8BABA	1.00138316049043	1
Diclofenac	Rifampicin	0.304	-2.51	Moderate	52 (16/36)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#ACCCE3	6.50899054318778	1
Pseudoephedrine	Clomipramine	0.091	-1.004	None	19 (10/9)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B4D1E6	2.37828500616477	1
Trospium	Haloperidol	0.248	1.793	Moderate	3 (2/1)		#F7B9B9	0.37551868518391	1
Estradiol	Phenobarbital	0.398	Inf	Moderate	2 (2/0)	The metabolism of Estradiol can be increased when combined with Phenobarbital.	#B32020	0.250345790122607	1
Prednisone	Estradiol	0.222	6.275	Moderate	16 (14/2)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#EDA1A1	2.00276632098085	1
Propranolol	Rifampicin	0.143	-1.785	Moderate	13 (5/8)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#B1CFE5	1.62724763579694	1
Cyclosporine	Diclofenac	0.119	-2.231	Moderate	45 (15/30)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#AECDE3	5.63278027775865	1
Fluvoxamine	Warfarin	0.394	1.345	Moderate	5 (3/2)	The metabolism of Warfarin can be decreased when combined with Fluvoxamine.	#F8BABA	0.625864475306517	1
Fluoxetine	Naratriptan	0.239	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Naratriptan.	#B32020	0.37551868518391	1
Imipramine	Rivastigmine	0.322	1.793	Moderate	3 (2/1)		#F7B9B9	0.37551868518391	1
Telmisartan	Lithium cation	0.232	-1.115	Moderate	14 (7/7)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#B4D1E6	1.75242053085825	1
Itraconazole	Acenocoumarol	0.079	-2.175	None	59 (20/39)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#AFCEE4	7.3852008086169	1
Miglitol	Glucosamine	0.129	-1.115	None	8 (4/4)		#B4D1E6	1.00138316049043	1
Warfarin	Cloxacillin	0.064	-1.487	Moderate	21 (9/12)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#B2D0E5	2.62863079628737	1
Trospium	Loratadine	0.199	2.689	None	12 (9/3)		#F5B4B4	1.50207474073564	1
Sumatriptan	Lithium cation	0.288	-1.487	None	7 (3/4)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.	#B2D0E5	0.876210265429124	1
Metoprolol	Ergotamine	0.469	Inf	Moderate	3 (3/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.37551868518391	1
Fluvastatin	Cholestyramine	0.292	-1.301	Moderate	13 (6/7)	The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.	#B4D1E6	1.62724763579694	1
Erythromycin	Bromocriptine	0.067	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Bromocriptine is combined with Erythromycin.	#B32020	0.125172895061303	1
Perphenazine	Levofloxacin	0.121	2.092	Moderate	10 (7/3)		#F7B7B7	1.25172895061303	1
Ofloxacin	Acenocoumarol	0.083	-2.789	None	21 (6/15)		#ACCCE3	2.62863079628737	1
Phenytoin	Fludrocortisone	0.514	-2.231	Moderate	3 (1/2)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#AECDE3	0.37551868518391	1
Trospium	Tiotropium	0.313	-1.952	Moderate	11 (4/7)	Trospium may increase the anticholinergic activities of Tiotropium.	#AFCEE4	1.37690184567434	1
Eletriptan	Fluoxetine	0.202	4.482	Major	6 (5/1)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#F1ABAB	0.751037370367821	1
Erythromycin	Eplerenone	0.168	-1.394	Moderate	9 (4/5)	The serum concentration of Eplerenone can be increased when it is combined with Erythromycin.	#B2D0E5	1.12655605555173	1
Nortriptyline	Galantamine	0.558	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Erythromycin	Quetiapine	0.178	1.972	Major	16 (11/5)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#F7B7B7	2.00276632098085	1
Cyclosporine	Diltiazem	0.432	-3.904	Moderate	18 (4/14)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#A6C7E0	2.25311211110346	1
Phenytoin	Midazolam	0.161	-1.115	Moderate	4 (2/2)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#B4D1E6	0.500691580245214	1
Rosuvastatin	Colchicine	0.199	-7.171	Moderate	52 (7/45)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#96BBD9	6.50899054318778	1
Warfarin	Gemfibrozil	0.196	-4.322	Major	39 (8/31)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#A3C5DF	4.88174290739083	1
Tacrolimus	Itraconazole	0.437	-1.673	Major	25 (10/15)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#B1CFE5	3.12932237653259	1
Prazosin	Verapamil	0.929	Inf	Moderate	1 (1/0)	The risk or severity of hypotension can be increased when Prazosin is combined with Verapamil.	#B32020	0.125172895061303	1
Medroxyprogesterone acetate	Acenocoumarol	0.483	Inf	None	3 (3/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.37551868518391	1
Carbamazepine	Bupropion	0.307	1.793	Moderate	6 (4/2)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#F7B9B9	0.751037370367821	1
Phenytoin	Tacrolimus	0.35	-1.115	Major	8 (4/4)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#B4D1E6	1.00138316049043	1
Disopyramide	Carvedilol	0.72	Inf	Major	1 (1/0)	Disopyramide may increase the bradycardic activities of Carvedilol.	#B32020	0.125172895061303	1
Ranolazine	Sotalol	0.111	Inf	Major	1 (1/0)	Ranolazine may increase the QTc-prolonging activities of Sotalol.	#B32020	0.125172895061303	1
Doxycycline	Insulin detemir	0.063	1.345	Moderate	10 (6/4)		#F8BABA	1.25172895061303	1
Felodipine	Itraconazole	0.061	3.586	Major	5 (4/1)	The serum concentration of Felodipine can be increased when it is combined with Itraconazole.	#F3AFAF	0.625864475306517	1
Meloxicam	Lithium cation	0.113	1.345	Major	10 (6/4)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#F8BABA	1.25172895061303	1
Piroxicam	Bisoprolol	0.112	-1.023	Moderate	23 (12/11)	Piroxicam may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	2.87897658640998	1
Fluvoxamine	Amitriptyline	0.352	1.614	Major	14 (9/5)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#F7B9B9	1.75242053085825	1
Amitriptyline	Moclobemide	0.577	1.793	None	3 (2/1)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#F7B9B9	0.37551868518391	1
Clonidine	Bisoprolol	0.168	1.345	Major	5 (3/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F8BABA	0.625864475306517	1
Prednisolone	Itraconazole	1	Inf	Moderate	2 (2/0)	The serum concentration of Prednisolone can be increased when it is combined with Itraconazole.	#B32020	0.250345790122607	1
Fludrocortisone	Acenocoumarol	0.171	3.586	None	5 (4/1)		#F3AFAF	0.625864475306517	1
Valsartan	Lithium cation	0.242	-2.045	Moderate	34 (12/22)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#AFCEE4	4.25587843208432	1
Phenytoin	Methylprednisolone	0.179	-1.562	Moderate	12 (5/7)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#B2D0E5	1.50207474073564	1
Chlorpromazine	Rivastigmine	0.287	-3.346	Moderate	4 (1/3)		#A9C9E1	0.500691580245214	1
Oxycodone	Cimetidine	0.188	-1.115	Major	2 (1/1)	The metabolism of Oxycodone can be decreased when combined with Cimetidine.	#B4D1E6	0.250345790122607	1
Terbutaline	Rasagiline	0.064	-2.045	Moderate	17 (6/11)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.	#AFCEE4	2.12793921604216	1
Dihydroergotamine	Nitroglycerin	0.198	-1.363	Moderate	20 (9/11)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#B2D0E5	2.50345790122607	1
Phenytoin	Trimethoprim	0.245	-2.51	Moderate	13 (4/9)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#ACCCE3	1.62724763579694	1
Chlorpropamide	Carvedilol	0.458	-1.115	Moderate	2 (1/1)	Carvedilol may increase the hypoglycemic activities of Chlorpropamide.	#B4D1E6	0.250345790122607	1
Sertraline	Moclobemide	0.314	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Sertraline is combined with Moclobemide.	#B32020	0.250345790122607	1
Triazolam	Clarithromycin	0.257	1.793	Moderate	6 (4/2)	The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.	#F7B9B9	0.751037370367821	1
Nabumetone	Methotrexate	0.282	-1.115	Major	12 (6/6)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#B4D1E6	1.50207474073564	1
Sotalol	Gliclazide	0.288	-3.16	None	23 (6/17)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#A9C9E1	2.87897658640998	1
Paroxetine	Selegiline	0.231	-1.115	Major	8 (4/4)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#B4D1E6	1.00138316049043	1
Methylprednisolone	Phenobarbital	0.067	-1.562	Moderate	12 (5/7)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#B2D0E5	1.50207474073564	1
Moxifloxacin	Iron	0.345	-1.264	Moderate	32 (15/17)		#B4D1E6	4.00553264196171	1
Rifabutin	Simvastatin	0.125	1.195	None	7 (4/3)	The metabolism of Simvastatin can be increased when combined with Rifabutin.	#F9BCBC	0.876210265429124	1
Dihydroergotamine	Frovatriptan	0.224	Inf	Major	1 (1/0)	Dihydroergotamine may increase the vasoconstricting activities of Frovatriptan.	#B32020	0.125172895061303	1
Spironolactone	Cilazapril	0.28	1.345	None	5 (3/2)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.	#F8BABA	0.625864475306517	1
Propranolol	Verapamil	0.26	-1.227	Major	21 (10/11)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#B4D1E6	2.62863079628737	1
Diltiazem	Carbamazepine	0.261	-2.649	Major	27 (8/19)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#ACCCE3	3.37966816665519	1
Trospium	Amitriptyline	0.244	2.689	Moderate	8 (6/2)		#F5B4B4	1.00138316049043	1
Clarithromycin	Colchicine	0.317	-1.487	Major	28 (12/16)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#B2D0E5	3.5048410617165	1
Donepezil	Zuclopenthixol	0.2	Inf	None	1 (1/0)		#B32020	0.125172895061303	1
Warfarin	Pentoxifylline	0.288	-8.738	Moderate	53 (6/47)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#8EB5D5	6.63416343824908	1
Fluoxetine	Cilostazol	0.302	-2.603	Moderate	20 (6/14)	The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.	#ACCCE3	2.50345790122607	1
Indomethacin	Lithium cation	0.061	2.689	Major	8 (6/2)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#F5B4B4	1.00138316049043	1
Acitretin	Methotrexate	0.314	-2.789	Major	7 (2/5)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#ACCCE3	0.876210265429124	1
Gliclazide	Nadolol	0.268	-1.594	None	17 (7/10)	Nadolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	2.12793921604216	1
Primidone	Nifedipine	0.137	Inf	Major	2 (2/0)	The serum concentration of Nifedipine can be decreased when it is combined with Primidone.	#B32020	0.250345790122607	1
Citalopram	Selegiline	0.292	-1.115	Major	8 (4/4)	The risk or severity of adverse effects can be increased when Citalopram is combined with Selegiline.	#B4D1E6	1.00138316049043	1
Cyclosporine	Methotrexate	0.138	-2.231	Moderate	9 (3/6)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#AECDE3	1.12655605555173	1
Rifampicin	Amiodarone	0.253	-1.859	Major	8 (3/5)	The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.	#B1CFE5	1.00138316049043	1
Prednisolone	Acetylsalicylic acid	0.119	-1.434	Moderate	16 (7/9)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#B2D0E5	2.00276632098085	1
Conjugated estrogens	Ursodeoxycholic acid	0.4	Inf	None	1 (1/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Conjugated estrogens.	#B32020	0.125172895061303	1
Morphine	Rifampicin	0.416	-5.02	Moderate	11 (2/9)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#A0C3DD	1.37690184567434	1
Frovatriptan	Escitalopram	0.284	2.689	Major	4 (3/1)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#F5B4B4	0.500691580245214	1
Rifampicin	Clomipramine	0.182	Inf	Minor	3 (3/0)	The metabolism of Clomipramine can be increased when combined with Rifampicin.	#B32020	0.37551868518391	1
Tizanidine	Captopril	0.246	1.046	Major	13 (7/6)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#F9BCBC	1.62724763579694	1
Almotriptan	Itraconazole	0.104	4.482	Moderate	6 (5/1)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#F1ABAB	0.751037370367821	1
Terbinafine	Acenocoumarol	0.089	-2.082	None	43 (15/28)		#AFCEE4	5.38243448763605	1
Fluvoxamine	Zolmitriptan	0.142	1.345	Moderate	5 (3/2)	The metabolism of Zolmitriptan can be decreased when combined with Fluvoxamine.	#F8BABA	0.625864475306517	1
Ketoconazole	Rabeprazole	0.201	1.793	Moderate	6 (4/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#F7B9B9	0.751037370367821	1
Clozapine	Norfloxacin	0.039	Inf	Major	2 (2/0)	Norfloxacin may increase the QTc-prolonging activities of Clozapine.	#B32020	0.250345790122607	1
Sertraline	Cilostazol	0.307	-3.718	Moderate	26 (6/20)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#A6C7E0	3.25449527159389	1
Warfarin	Hydrocortisone	0.187	-1.394	Moderate	18 (8/10)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#B2D0E5	2.25311211110346	1
Carbamazepine	Midazolam	0.293	-1.487	Moderate	7 (3/4)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#B2D0E5	0.876210265429124	1
Theophylline	Pentoxifylline	0.318	-6.693	Moderate	28 (4/24)	The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.	#99BDDA	3.5048410617165	1
Metoprolol	Primidone	0.503	-1.115	Moderate	2 (1/1)	The serum concentration of Metoprolol can be decreased when it is combined with Primidone.	#B4D1E6	0.250345790122607	1
Pioglitazone	Glucosamine	0.185	1.494	None	16 (10/6)		#F8BABA	2.00276632098085	1
Fluorouracil	Acenocoumarol	0.074	1.195	None	7 (4/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluorouracil.	#F9BCBC	0.876210265429124	1
Tizanidine	Perindopril	0.304	1.195	Major	7 (4/3)	The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.	#F9BCBC	0.876210265429124	1
Fluconazole	Ergotamine	0.104	3.138	Moderate	9 (7/2)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#F4B1B1	1.12655605555173	1
Risperidone	Itraconazole	0.13	-1.813	None	21 (8/13)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#B1CFE5	2.62863079628737	1
Minocycline	Cloxacillin	0.833	1.121	Moderate	9 (5/4)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#F9BCBC	1.12655605555173	1
Trospium	Maprotiline	0.069	-1.115	Moderate	2 (1/1)		#B4D1E6	0.250345790122607	1
Tetracycline	Insulin aspart	0.037	4.482	Moderate	6 (5/1)		#F1ABAB	0.751037370367821	1
Donepezil	Clomipramine	0.35	1.195	Moderate	7 (4/3)	The metabolism of Donepezil can be decreased when combined with Clomipramine.	#F9BCBC	0.876210265429124	1
Fluvoxamine	Almotriptan	0.181	Inf	Major	2 (2/0)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#B32020	0.250345790122607	1
Trospium	Ipratropium	0.217	3.138	Moderate	9 (7/2)	The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Trospium.	#F4B1B1	1.12655605555173	1
Ticlopidine	Acetylsalicylic acid	0.222	-4.462	Moderate	30 (6/24)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#A3C5DF	3.7551868518391	1
Triamcinolone	Acenocoumarol	0.127	-3.215	None	66 (17/49)		#A9C9E1	8.26141107404603	1
Methotrexate	Cholestyramine	0.138	-2.008	None	14 (5/9)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#AFCEE4	1.75242053085825	1
Metoprolol	Verapamil	0.23	1.345	Major	5 (3/2)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#F8BABA	0.625864475306517	1
Metoprolol	Propafenone	0.332	-1.115	Moderate	4 (2/2)	The serum concentration of Metoprolol can be increased when it is combined with Propafenone.	#B4D1E6	0.500691580245214	1
Omeprazole	Chlordiazepoxide	0.304	1.195	Moderate	7 (4/3)		#F9BCBC	0.876210265429124	1
Theophylline	Verapamil	0.405	-2.975	Moderate	11 (3/8)	The metabolism of Theophylline can be decreased when combined with Verapamil.	#ABCBE2	1.37690184567434	1
Fluconazole	Ranolazine	0.382	Inf	Major	3 (3/0)	The serum concentration of Ranolazine can be increased when it is combined with Fluconazole.	#B32020	0.37551868518391	1
Primidone	Estriol	0.216	Inf	None	2 (2/0)		#B32020	0.250345790122607	1
Betamethasone	Acenocoumarol	0.096	1.153	None	16 (9/7)		#F9BCBC	2.00276632098085	1
Phenytoin	Triamcinolone	0.063	-1.952	Moderate	11 (4/7)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#AFCEE4	1.37690184567434	1
Phenobarbital	Dexamethasone	0.204	-1.115	Moderate	8 (4/4)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#B4D1E6	1.00138316049043	1
Indapamide	Lithium cation	0.235	-1.487	Major	14 (6/8)	Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.	#B2D0E5	1.75242053085825	1
Telithromycin	Amiodarone	0.134	-1.115	Major	2 (1/1)	Telithromycin may increase the QTc-prolonging activities of Amiodarone.	#B4D1E6	0.250345790122607	1
Levofloxacin	Josamycin	0.661	1.195	None	14 (8/6)		#F9BCBC	1.75242053085825	1
Hydroxyzine	Rivastigmine	0.208	-1.487	Moderate	14 (6/8)		#B2D0E5	1.75242053085825	1
Nortriptyline	Salbutamol	0.177	-1.239	Moderate	19 (9/10)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#B4D1E6	2.37828500616477	1
Ketoconazole	Aripiprazole	0.346	-1.115	Moderate	2 (1/1)	The serum concentration of Aripiprazole can be increased when it is combined with Ketoconazole.	#B4D1E6	0.250345790122607	1
Citalopram	Frovatriptan	0.325	3.586	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#F3AFAF	0.625864475306517	1
Glyburide	Rifampicin	0.23	-1.673	Moderate	10 (4/6)	The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.	#B1CFE5	1.25172895061303	1
Salmeterol	Nadolol	0.307	-3.532	Major	25 (6/19)		#A8C8E1	3.12932237653259	1
Ergotamine	Frovatriptan	0.069	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#B32020	0.125172895061303	1
Fentanyl	Ketoconazole	0.208	-1.859	Major	8 (3/5)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#B1CFE5	1.00138316049043	1
Cyclosporine	Carbamazepine	0.257	-1.115	Major	4 (2/2)	The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.	#B4D1E6	0.500691580245214	1
Labetalol	Salmeterol	0.279	-1.115	Major	4 (2/2)	Labetalol may decrease the vasoconstricting activities of Salmeterol.	#B4D1E6	0.500691580245214	1
Pimozide	Escitalopram	0.096	-1.673	Major	5 (2/3)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#B1CFE5	0.625864475306517	1
Midazolam	Itraconazole	0.304	1.195	Major	7 (4/3)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#F9BCBC	0.876210265429124	1
Phenytoin	Mirtazapine	0.312	-2.454	Moderate	16 (5/11)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#AECDE3	2.00276632098085	1
Indomethacin	Nadolol	0.207	3.586	Moderate	5 (4/1)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#F3AFAF	0.625864475306517	1
Citalopram	Naratriptan	0.258	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#B32020	0.37551868518391	1
Cyclosporine	Clarithromycin	0.155	1.793	Major	9 (6/3)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#F7B9B9	1.12655605555173	1
Pseudoephedrine	Rasagiline	0.064	1.793	Moderate	6 (4/2)	Rasagiline may increase the hypertensive activities of Pseudoephedrine.	#F7B9B9	0.751037370367821	1
Donepezil	Glycopyrronium	0.237	-1.673	None	5 (2/3)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.	#B1CFE5	0.625864475306517	1
Sotalol	Clarithromycin	0.078	1.076	Major	11 (6/5)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#F9BCBC	1.37690184567434	1
Pregabalin	Rosiglitazone	0.209	-1.594	Moderate	17 (7/10)	The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.	#B2D0E5	2.12793921604216	1
Imipramine	Galantamine	0.105	-1.115	Moderate	2 (1/1)	The metabolism of Galantamine can be decreased when combined with Imipramine.	#B4D1E6	0.250345790122607	1
Doxycycline	Digoxin	0.2	-1.487	Moderate	14 (6/8)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#B2D0E5	1.75242053085825	1
Cyclosporine	Repaglinide	0.239	-6.693	Major	21 (3/18)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#99BDDA	2.62863079628737	1
Fluconazole	Warfarin	0.096	1.076	Major	11 (6/5)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#F9BCBC	1.37690184567434	1
Fluvoxamine	Sumatriptan	0.371	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.	#B32020	0.250345790122607	1
Phenytoin	Disulfiram	0.233	-1.115	Moderate	2 (1/1)	The serum concentration of Phenytoin can be increased when it is combined with Disulfiram.	#B4D1E6	0.250345790122607	1
Chlorthalidone	Lithium cation	0.138	3.586	Major	5 (4/1)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#F3AFAF	0.625864475306517	1
Warfarin	Cholestyramine	0.122	-1.487	Moderate	7 (3/4)	Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	0.876210265429124	1
Thiethylperazine	Levofloxacin	0.551	2.818	None	29 (22/7)		#F5B2B2	3.6300139567778	1
Warfarin	Clarithromycin	0.167	-1.825	Major	29 (11/18)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#B1CFE5	3.6300139567778	1
Trospium	Olanzapine	0.109	1.793	Moderate	3 (2/1)		#F7B9B9	0.37551868518391	1
Metoprolol	Dihydroergotamine	0.594	1.793	Moderate	3 (2/1)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#F7B9B9	0.37551868518391	1
Amikacin	Furosemide	0.294	-4.462	Major	5 (1/4)	The serum concentration of Amikacin can be increased when it is combined with Furosemide.	#A3C5DF	0.625864475306517	1
Ticlopidine	Carbamazepine	0.502	-5.577	Moderate	6 (1/5)	The metabolism of Ticlopidine can be increased when combined with Carbamazepine.	#9DC0DC	0.751037370367821	1
Methylprednisolone	Itraconazole	0.42	-1.004	Major	19 (10/9)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#B4D1E6	2.37828500616477	1
Perphenazine	Rivastigmine	0.143	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Clonidine	Carvedilol	0.213	-2.231	Major	3 (1/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#AECDE3	0.37551868518391	1
Cyclosporine	Methylphenidate	0.707	Inf	Minor	1 (1/0)		#B32020	0.125172895061303	1
Cimetidine	Clomipramine	0.021	Inf	Moderate	1 (1/0)	The metabolism of Clomipramine can be decreased when combined with Cimetidine.	#B32020	0.125172895061303	1
Lovastatin	Niacin	0.667	Inf	Major	1 (1/0)	The risk or severity of rhabdomyolysis can be increased when Niacin is combined with Lovastatin.	#B32020	0.125172895061303	1
Tetracycline	Amoxicillin	0.575	2.241	Moderate	35 (25/10)		#F6B6B6	4.38105132714562	1
Glyburide	Oxprenolol	0.071	Inf	None	1 (1/0)	Oxprenolol may increase the hypoglycemic activities of Glyburide.	#B32020	0.125172895061303	1
Theophylline	Disulfiram	0.186	-2.231	Moderate	3 (1/2)	The serum concentration of Theophylline can be increased when it is combined with Disulfiram.	#AECDE3	0.37551868518391	1
Doxycycline	Rifampicin	0.776	-4.462	Moderate	10 (2/8)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#A3C5DF	1.25172895061303	1
Erythromycin	Amiodarone	0.173	-2.072	Major	20 (7/13)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#AFCEE4	2.50345790122607	1
Celecoxib	Lithium cation	0.166	2.391	Major	11 (8/3)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#F6B6B6	1.37690184567434	1
Raloxifene	Cholestyramine	0.115	Inf	Moderate	7 (7/0)	Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.876210265429124	1
Phenytoin	Estriol	0.157	Inf	None	3 (3/0)		#B32020	0.37551868518391	1
Cyclosporine	Rosuvastatin	0.181	-1.859	Major	8 (3/5)	The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.	#B1CFE5	1.00138316049043	1
Ergotamine	Nitroglycerin	0.185	1.195	Moderate	14 (8/6)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#F9BCBC	1.75242053085825	1
Acetaminophen	Imatinib	0.037	Inf	Moderate	1 (1/0)	Acetaminophen may increase the hepatotoxic activities of Imatinib.	#B32020	0.125172895061303	1
Warfarin	Naproxen	0.132	-1.468	Major	44 (19/25)	Naproxen may increase the anticoagulant activities of Warfarin.	#B2D0E5	5.50760738269735	1
Sucralfate	Norfloxacin	0.215	1.059	Moderate	24 (13/11)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#F9BCBC	3.00414948147128	1
Atenolol	Isoprenaline	0.111	Inf	Moderate	1 (1/0)	Atenolol may decrease the bronchodilatory activities of Isoprenaline.	#B32020	0.125172895061303	1
Digoxin	Josamycin	0.093	-1.487	None	7 (3/4)	The serum concentration of Digoxin can be increased when it is combined with Josamycin.	#B2D0E5	0.876210265429124	1
Imipramine	Terbutaline	0.086	Inf	Moderate	4 (4/0)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#B32020	0.500691580245214	1
Cyclobenzaprine	Rasagiline	0.054	-1.859	Major	16 (6/10)	Cyclobenzaprine may increase the serotonergic activities of Rasagiline.	#B1CFE5	2.00276632098085	1
Lidocaine	Nadolol	0.154	Inf	Moderate	3 (3/0)	The serum concentration of Lidocaine can be increased when it is combined with Nadolol.	#B32020	0.37551868518391	1
Meloxicam	Acenocoumarol	0.155	-2.305	None	46 (15/31)	Meloxicam may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	5.75795317281996	1
Valproic acid	Nimodipine	0.344	-2.603	Minor	10 (3/7)		#ACCCE3	1.25172895061303	1
Digoxin	Bumetanide	0.556	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Bumetanide is combined with Digoxin.	#B32020	0.125172895061303	1
Doxycycline	Insulin aspart	0.097	-1.301	Moderate	13 (6/7)		#B4D1E6	1.62724763579694	1
Triamcinolone	Primidone	0.077	Inf	Moderate	2 (2/0)	The metabolism of Triamcinolone can be increased when combined with Primidone.	#B32020	0.250345790122607	1
Celecoxib	Warfarin	0.201	1.153	Moderate	16 (9/7)	Celecoxib may increase the anticoagulant activities of Warfarin.	#F9BCBC	2.00276632098085	1
Telithromycin	Atorvastatin	0.258	-2.603	Major	10 (3/7)	The risk or severity of adverse effects can be increased when Telithromycin is combined with Atorvastatin.	#ACCCE3	1.25172895061303	1
Pyridostigmine	Dexamethasone	0.114	1.793	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pyridostigmine.	#F7B9B9	0.37551868518391	1
Verapamil	Rifampicin	0.2	-1.673	Moderate	5 (2/3)	The metabolism of Verapamil can be increased when combined with Rifampicin.	#B1CFE5	0.625864475306517	1
Ergotamine	Itraconazole	0.097	4.482	Major	6 (5/1)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#F1ABAB	0.751037370367821	1
Trospium	Rivastigmine	0.171	-2.231	Moderate	3 (1/2)	The therapeutic efficacy of Trospium can be decreased when used in combination with Rivastigmine.	#AECDE3	0.37551868518391	1
Colestipol	Digoxin	0.301	-1.115	Moderate	4 (2/2)	Colestipol can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.500691580245214	1
Pimozide	Sertraline	0.3	1.793	Major	3 (2/1)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#F7B9B9	0.37551868518391	1
Cyclosporine	Phenytoin	0.737	Inf	Moderate	1 (1/0)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#B32020	0.125172895061303	1
Donepezil	Perphenazine	0.429	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Imipramine	Pseudoephedrine	0.141	1.345	None	5 (3/2)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#F8BABA	0.625864475306517	1
Erythromycin	Dihydroergotamine	0.277	1.195	Major	7 (4/3)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#F9BCBC	0.876210265429124	1
Eplerenone	Clarithromycin	0.099	-2.603	Major	20 (6/14)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#ACCCE3	2.50345790122607	1
Piroxicam	Propranolol	0.077	3.586	Moderate	5 (4/1)	Piroxicam may decrease the antihypertensive activities of Propranolol.	#F3AFAF	0.625864475306517	1
Cyclosporine	Piroxicam	0.097	-2.231	Moderate	3 (1/2)	Piroxicam may increase the nephrotoxic activities of Cyclosporine.	#AECDE3	0.37551868518391	1
Capecitabine	Acenocoumarol	0.174	1.345	None	5 (3/2)	The serum concentration of Acenocoumarol can be increased when it is combined with Capecitabine.	#F8BABA	0.625864475306517	1
Tacrolimus	Clarithromycin	0.137	1.569	Major	22 (14/8)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#F8BABA	2.75380369134868	1
Trospium	Clomipramine	0.199	-2.231	Moderate	6 (2/4)		#AECDE3	0.751037370367821	1
Sotalol	Piroxicam	0.1	Inf	Moderate	1 (1/0)	Piroxicam may decrease the antihypertensive activities of Sotalol.	#B32020	0.125172895061303	1
Galantamine	Oxybutynin	0.551	-1.115	Moderate	2 (1/1)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Galantamine.	#B4D1E6	0.250345790122607	1
Metronidazole	Lithium cation	0.11	1.494	Moderate	8 (5/3)		#F8BABA	1.00138316049043	1
Ceftriaxone	Acenocoumarol	0.02	Inf	None	1 (1/0)	Ceftriaxone may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.125172895061303	1
Formoterol	Nadolol	0.146	-2.045	Major	17 (6/11)		#AFCEE4	2.12793921604216	1
Tetracycline	Acenocoumarol	0.072	1.793	None	9 (6/3)		#F7B9B9	1.12655605555173	1
Imipramine	Rifampicin	0.018	Inf	Minor	1 (1/0)	The metabolism of Imipramine can be increased when combined with Rifampicin.	#B32020	0.125172895061303	1
Metoprolol	Lidocaine	0.241	Inf	Moderate	3 (3/0)	The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.	#B32020	0.37551868518391	1
Ranolazine	Digoxin	0.22	-2.231	Moderate	6 (2/4)	The serum concentration of Digoxin can be increased when it is combined with Ranolazine.	#AECDE3	0.751037370367821	1
Tizanidine	Quinapril	0.173	1.345	Major	5 (3/2)	The risk or severity of hypotension can be increased when Tizanidine is combined with Quinapril.	#F8BABA	0.625864475306517	1
Salbutamol	Oxprenolol	0.05	Inf	None	2 (2/0)	Oxprenolol may decrease the bronchodilatory activities of Salbutamol.	#B32020	0.250345790122607	1
Phenytoin	Itraconazole	0.04	-1.487	Moderate	7 (3/4)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#B2D0E5	0.876210265429124	1
Propranolol	Epinephrine	0.21	-1.115	Major	8 (4/4)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#B4D1E6	1.00138316049043	1
Fluvoxamine	Nortriptyline	0.509	-3.346	Major	4 (1/3)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#A9C9E1	0.500691580245214	1
Quinapril	Lithium cation	0.322	Inf	Moderate	2 (2/0)	The serum concentration of Lithium can be increased when it is combined with Quinapril.	#B32020	0.250345790122607	1
Sotalol	Glyburide	0.154	-4.462	Moderate	15 (3/12)	Sotalol may increase the hypoglycemic activities of Glyburide.	#A3C5DF	1.87759342591955	1
Itraconazole	Quazepam	0.115	Inf	None	1 (1/0)	The metabolism of Quazepam can be decreased when combined with Itraconazole.	#B32020	0.125172895061303	1
Warfarin	Capecitabine	0.062	Inf	Major	1 (1/0)	The serum concentration of Warfarin can be increased when it is combined with Capecitabine.	#B32020	0.125172895061303	1
Betamethasone	Pyridostigmine	0.091	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Betamethasone is combined with Pyridostigmine.	#B32020	0.125172895061303	1
Theophylline	Rifampicin	0.125	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be increased when combined with Rifampicin.	#B32020	0.125172895061303	1
Dihydroergotamine	Ketoconazole	1	Inf	Major	1 (1/0)	The serum concentration of Dihydroergotamine can be increased when it is combined with Ketoconazole.	#B32020	0.125172895061303	1
Metoprolol	Glipizide	0.673	-2.231	Moderate	3 (1/2)	Metoprolol may increase the hypoglycemic activities of Glipizide.	#AECDE3	0.37551868518391	1
Prednisone	Primidone	0.13	-2.454	Moderate	16 (5/11)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#AECDE3	2.00276632098085	1
Fosinopril	Tizanidine	0.306	-1.115	Major	4 (2/2)	The risk or severity of hypotension can be increased when Tizanidine is combined with Fosinopril.	#B4D1E6	0.500691580245214	1
Haloperidol	Ketoconazole	0.537	-2.231	Major	3 (1/2)	The metabolism of Haloperidol can be decreased when combined with Ketoconazole.	#AECDE3	0.37551868518391	1
Phenytoin	Doxycycline	0.051	-2.789	Moderate	7 (2/5)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#ACCCE3	0.876210265429124	1
Eletriptan	Ergotamine	0.167	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#B32020	0.125172895061303	1
Dextromethorphan	Rasagiline	0.055	-1.301	Major	13 (6/7)	Rasagiline may increase the serotonergic activities of Dextromethorphan.	#B4D1E6	1.62724763579694	1
Atenolol	Ampicillin	0.283	1.345	Moderate	5 (3/2)	The bioavailability of Atenolol can be decreased when combined with Ampicillin.	#F8BABA	0.625864475306517	1
Fluorouracil	Warfarin	0.077	Inf	Major	1 (1/0)	The serum concentration of Warfarin can be increased when it is combined with Fluorouracil.	#B32020	0.125172895061303	1
Pantoprazole	Ketoconazole	0.19	-1.952	Moderate	11 (4/7)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#AFCEE4	1.37690184567434	1
Esomeprazole	Ketoconazole	0.229	-1.859	Moderate	8 (3/5)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#B1CFE5	1.00138316049043	1
Warfarin	Tetracycline	0.068	1.793	Moderate	3 (2/1)		#F7B9B9	0.37551868518391	1
Theophylline	Carbamazepine	0.252	-1.115	Moderate	4 (2/2)	The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.	#B4D1E6	0.500691580245214	1
Ibuprofen	Oxprenolol	0.085	1.793	None	6 (4/2)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#F7B9B9	0.751037370367821	1
Itraconazole	Aripiprazole	0.049	1.345	Moderate	5 (3/2)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#F8BABA	0.625864475306517	1
Maprotiline	Rivastigmine	0.125	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Trospium	Oxybutynin	0.123	-2.231	Moderate	3 (1/2)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#AECDE3	0.37551868518391	1
Galantamine	Biperiden	0.174	-2.231	Moderate	3 (1/2)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Galantamine.	#AECDE3	0.37551868518391	1
Warfarin	Primidone	0.239	-3.346	Major	4 (1/3)	The metabolism of Warfarin can be increased when combined with Primidone.	#A9C9E1	0.500691580245214	1
Erythromycin	Everolimus	0.025	Inf	Major	1 (1/0)	The serum concentration of Everolimus can be increased when it is combined with Erythromycin.	#B32020	0.125172895061303	1
Doxycycline	Phenobarbital	0.123	-1.115	Moderate	4 (2/2)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#B4D1E6	0.500691580245214	1
Methotrexate	Tetracycline	0.155	Inf	Moderate	3 (3/0)		#B32020	0.37551868518391	1
Fluoxetine	Trimipramine	0.033	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#B32020	0.125172895061303	1
Rifabutin	Clarithromycin	0.521	-4.462	Moderate	5 (1/4)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#A3C5DF	0.625864475306517	1
Erythromycin	Ergotamine	0.274	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Erythromycin.	#B32020	0.500691580245214	1
Warfarin	Ketoconazole	0.1	Inf	Moderate	1 (1/0)	The serum concentration of Warfarin can be increased when it is combined with Ketoconazole.	#B32020	0.125172895061303	1
Rifampicin	Etoricoxib	0.111	-1.115	None	8 (4/4)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#B4D1E6	1.00138316049043	1
Fluconazole	Halazepam	0.112	Inf	None	3 (3/0)		#B32020	0.37551868518391	1
Cyclosporine	Naproxen	0.125	-1.673	Moderate	20 (8/12)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	2.50345790122607	1
Piroxicam	Carvedilol	0.089	-1.487	Moderate	7 (3/4)	Piroxicam may decrease the antihypertensive activities of Carvedilol.	#B2D0E5	0.876210265429124	1
Terbutaline	Nadolol	0.059	1.345	Major	5 (3/2)		#F8BABA	0.625864475306517	1
Fluconazole	Imipramine	0.13	-1.859	Moderate	8 (3/5)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#B1CFE5	1.00138316049043	1
Chlorpropamide	Glucosamine	0.1	Inf	None	1 (1/0)		#B32020	0.125172895061303	1
Trospium	Hydroxyzine	0.248	1.345	Moderate	5 (3/2)		#F8BABA	0.625864475306517	1
Estradiol	Ursodeoxycholic acid	0.132	Inf	None	2 (2/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#B32020	0.250345790122607	1
Prazosin	Bisoprolol	0.332	-1.115	Moderate	4 (2/2)	Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.	#B4D1E6	0.500691580245214	1
Doxycycline	Iron	0.28	-1.115	Moderate	10 (5/5)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	1.25172895061303	1
Fluconazole	Dihydroergotamine	0.558	Inf	Moderate	4 (4/0)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#B32020	0.500691580245214	1
Trospium	Biperiden	0.323	-3.346	Moderate	4 (1/3)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#A9C9E1	0.500691580245214	1
Colestipol	Warfarin	0.23	-1.115	Minor	2 (1/1)	Colestipol can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.250345790122607	1
Theophylline	Josamycin	0.556	-1.115	None	2 (1/1)	The metabolism of Theophylline can be decreased when combined with Josamycin.	#B4D1E6	0.250345790122607	1
Disulfiram	Acenocoumarol	0.361	-4.462	None	15 (3/12)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#A3C5DF	1.87759342591955	1
Alendronic acid	Mefenamic acid	0.181	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Alendronic acid.	#B32020	0.250345790122607	1
Amitriptyline	Rifampicin	0.089	-1.115	Minor	8 (4/4)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#B4D1E6	1.00138316049043	1
Gliclazide	Oxprenolol	1	-1.115	None	2 (1/1)	Oxprenolol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	0.250345790122607	1
Clarithromycin	Everolimus	0.047	1.793	Major	3 (2/1)	The serum concentration of Everolimus can be increased when it is combined with Clarithromycin.	#F7B9B9	0.37551868518391	1
Cyclophosphamide	Acenocoumarol	0.292	-4.462	None	10 (2/8)		#A3C5DF	1.25172895061303	1
Moxifloxacin	Josamycin	0.576	-1.115	None	6 (3/3)		#B4D1E6	0.751037370367821	1
Epinephrine	Nadolol	0.062	Inf	Major	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.125172895061303	1
Atomoxetine	Paroxetine	0.059	Inf	Major	1 (1/0)	The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.	#B32020	0.125172895061303	1
Amitriptyline	Epinephrine	0.085	4.482	Major	6 (5/1)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#F1ABAB	0.751037370367821	1
Pyridostigmine	Hydrocortisone	0.169	-1.673	Moderate	5 (2/3)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#B1CFE5	0.625864475306517	1
Erythromycin	Tacrolimus	0.253	-1.562	Major	12 (5/7)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#B2D0E5	1.50207474073564	1
Diltiazem	Sirolimus	0.532	-1.115	Moderate	2 (1/1)	The metabolism of Sirolimus can be decreased when combined with Diltiazem.	#B4D1E6	0.250345790122607	1
Trazodone	Ketoconazole	0.147	-1.673	Moderate	5 (2/3)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#B1CFE5	0.625864475306517	1
Propranolol	Hydralazine	0.36	-2.603	Minor	10 (3/7)	Hydralazine may increase the hypotensive activities of Propranolol.	#ACCCE3	1.25172895061303	1
Rifampicin	Propafenone	0.039	-2.231	Moderate	3 (1/2)	The serum concentration of Propafenone can be decreased when it is combined with Rifampicin.	#AECDE3	0.37551868518391	1
Phenytoin	Theophylline	0.048	Inf	Moderate	1 (1/0)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#B32020	0.125172895061303	1
Methylphenidate	Rasagiline	0.246	-4.462	Moderate	5 (1/4)	Rasagiline may increase the hypertensive activities of Methylphenidate.	#A3C5DF	0.625864475306517	1
Nateglinide	Glucosamine	1	Inf	None	1 (1/0)		#B32020	0.125172895061303	1
Doxycycline	Acenocoumarol	0.089	-5.259	None	40 (7/33)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#9FC1DD	5.00691580245214	1
Sotalol	Repaglinide	0.259	-6.135	Moderate	13 (2/11)		#9ABEDB	1.62724763579694	1
Cimetidine	Fentanyl	0.143	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Erythromycin	Triazolam	0.128	-1.115	Moderate	2 (1/1)	The serum concentration of Triazolam can be increased when it is combined with Erythromycin.	#B4D1E6	0.250345790122607	1
Frovatriptan	Sertraline	0.219	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#B32020	0.250345790122607	1
Warfarin	Isoniazid	0.162	-1.115	Moderate	2 (1/1)	The metabolism of Warfarin can be decreased when combined with Isoniazid.	#B4D1E6	0.250345790122607	1
Metoprolol	Phenobarbital	1	Inf	Moderate	1 (1/0)	The serum concentration of Metoprolol can be decreased when it is combined with Phenobarbital.	#B32020	0.125172895061303	1
Fluconazole	Everolimus	0.284	-2.231	Major	3 (1/2)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#AECDE3	0.37551868518391	1
Theophylline	Phenobarbital	0.462	-2.231	Moderate	3 (1/2)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#AECDE3	0.37551868518391	1
Rifampicin	Bupropion	0.333	Inf	Moderate	1 (1/0)	The metabolism of Bupropion can be increased when combined with Rifampicin.	#B32020	0.125172895061303	1
Fluvoxamine	Imipramine	0.125	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#B32020	0.125172895061303	1
Cyclosporine	Colchicine	0.056	-5.577	Major	6 (1/5)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#9DC0DC	0.751037370367821	1
Tizanidine	Donepezil	0.208	-1.115	Moderate	4 (2/2)	Tizanidine may increase the bradycardic activities of Donepezil.	#B4D1E6	0.500691580245214	1
Fluvoxamine	Ropinirole	0.208	Inf	Moderate	1 (1/0)	Fluvoxamine may increase the sedative activities of Ropinirole.	#B32020	0.125172895061303	1
Imipramine	Terbinafine	0.055	Inf	Moderate	2 (2/0)	The metabolism of Imipramine can be decreased when combined with Terbinafine.	#B32020	0.250345790122607	1
Dihydroergotamine	Sotalol	0.25	Inf	Moderate	1 (1/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#B32020	0.125172895061303	1
Tetracycline	Iron	0.381	1.345	Moderate	5 (3/2)		#F8BABA	0.625864475306517	1
Moxifloxacin	Sucralfate	0.439	1.121	Moderate	9 (5/4)		#F9BCBC	1.12655605555173	1
Ampicillin	Methotrexate	0.2	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Ampicillin.	#B32020	0.125172895061303	1
Lovastatin	Colchicine	0.26	-9.667	Major	29 (3/26)	The serum concentration of Colchicine can be increased when it is combined with Lovastatin.	#89B1D3	3.6300139567778	1
Disopyramide	Levofloxacin	0.175	-1.115	Major	2 (1/1)	Levofloxacin may increase the QTc-prolonging activities of Disopyramide.	#B4D1E6	0.250345790122607	1
Diazepam	Ketoconazole	0.205	-1.339	Moderate	11 (5/6)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#B2D0E5	1.37690184567434	1
Tetracycline	Insulin detemir	0.03	1.793	Moderate	3 (2/1)		#F7B9B9	0.37551868518391	1
Prednisone	Ketoconazole	0.454	-4.462	Moderate	20 (4/16)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#A3C5DF	2.50345790122607	1
Ketoconazole	Clonazepam	0.136	-1.673	None	5 (2/3)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#B1CFE5	0.625864475306517	1
Cyclosporine	Indomethacin	0.157	-5.02	Moderate	11 (2/9)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#A0C3DD	1.37690184567434	1
Fluoxetine	Moclobemide	0.275	-2.231	None	3 (1/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Moclobemide.	#AECDE3	0.37551868518391	1
Phenytoin	Methotrexate	0.209	-2.789	Moderate	7 (2/5)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#ACCCE3	0.876210265429124	1
Metronidazole	Phenobarbital	0.053	-2.603	Moderate	10 (3/7)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#ACCCE3	1.25172895061303	1
Verapamil	Lithium cation	0.199	-3.346	Moderate	8 (2/6)	Verapamil may increase the neurotoxic activities of Lithium.	#A9C9E1	1.00138316049043	1
Haloperidol	Rifampicin	0.312	-1.115	Major	2 (1/1)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#B4D1E6	0.250345790122607	1
Donepezil	Cyclobenzaprine	0.079	-1.115	Moderate	8 (4/4)		#B4D1E6	1.00138316049043	1
Phenytoin	Megestrol acetate	0.108	-4.462	Moderate	5 (1/4)		#A3C5DF	0.625864475306517	1
Rifampicin	Acenocoumarol	0.151	-3.346	None	12 (3/9)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#A9C9E1	1.50207474073564	1
Digoxin	Minocycline	0.06	1.793	Moderate	3 (2/1)		#F7B9B9	0.37551868518391	1
Erythromycin	Itraconazole	0.63	1.121	Major	9 (5/4)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#F9BCBC	1.12655605555173	1
Eprosartan	Lithium cation	0.291	-2.231	Moderate	6 (2/4)	The serum concentration of Lithium can be increased when it is combined with Eprosartan.	#AECDE3	0.751037370367821	1
Itraconazole	Josamycin	0.545	Inf	None	2 (2/0)		#B32020	0.250345790122607	1
Alprazolam	Telithromycin	0.196	1.793	Moderate	3 (2/1)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#F7B9B9	0.37551868518391	1
Sotalol	Terbutaline	0.045	-1.673	Major	5 (2/3)	Terbutaline may increase the QTc-prolonging activities of Sotalol.	#B1CFE5	0.625864475306517	1
Megestrol acetate	Phenobarbital	0.024	-3.346	Moderate	4 (1/3)		#A9C9E1	0.500691580245214	1
Raloxifene	Estradiol	0.36	2.689	Moderate	4 (3/1)		#F5B4B4	0.500691580245214	1
Erythromycin	Theophylline	0.216	-2.231	Moderate	6 (2/4)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#AECDE3	0.751037370367821	1
Carbamazepine	Isoniazid	0.5	Inf	Moderate	1 (1/0)	The metabolism of Carbamazepine can be decreased when combined with Isoniazid.	#B32020	0.125172895061303	1
Tizanidine	Cilazapril	0.062	Inf	None	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Cilazapril.	#B32020	0.125172895061303	1
Rifampicin	Gliclazide	0.106	-5.949	None	19 (3/16)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#9CBFDB	2.37828500616477	1
Sotalol	Ergotamine	0.167	Inf	Moderate	1 (1/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#B32020	0.125172895061303	1
Warfarin	Metronidazole	0.152	-2.789	Major	14 (4/10)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#ACCCE3	1.75242053085825	1
Amitriptyline	Clonidine	0.393	-1.115	Major	2 (1/1)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B4D1E6	0.250345790122607	1
Repaglinide	Nadolol	0.316	-3.904	Moderate	9 (2/7)		#A6C7E0	1.12655605555173	1
Diltiazem	Triazolam	0.222	Inf	Moderate	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Diltiazem.	#B32020	0.125172895061303	1
Rivastigmine	Oxybutynin	0.087	-2.231	Moderate	3 (1/2)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Rivastigmine.	#AECDE3	0.37551868518391	1
Halazepam	Itraconazole	0.116	-2.789	None	7 (2/5)		#ACCCE3	0.876210265429124	1
Phenytoin	Mebendazole	0.131	-2.231	Moderate	3 (1/2)	The serum concentration of Mebendazole can be decreased when it is combined with Phenytoin.	#AECDE3	0.37551868518391	1
Moxifloxacin	Sotalol	0.285	-1.673	Major	5 (2/3)	Moxifloxacin may increase the QTc-prolonging activities of Sotalol.	#B1CFE5	0.625864475306517	1
Cyclosporine	Glyburide	0.337	-3.904	Moderate	9 (2/7)	The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.	#A6C7E0	1.12655605555173	1
Primidone	Acenocoumarol	0.182	-7.251	None	15 (2/13)	The metabolism of Acenocoumarol can be increased when combined with Primidone.	#96BBD9	1.87759342591955	1
Trandolapril	Lithium cation	0.045	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Trandolapril.	#B32020	0.125172895061303	1
Trospium	Desloratadine	0.297	-1.115	None	4 (2/2)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#B4D1E6	0.500691580245214	1
Allopurinol	Azathioprine	0.267	-8.924	Major	27 (3/24)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#8CB4D5	3.37966816665519	1
Celecoxib	Rifampicin	0.291	-2.603	Moderate	10 (3/7)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#ACCCE3	1.25172895061303	1
Ranolazine	Verapamil	0.184	-1.115	Major	2 (1/1)	The serum concentration of Ranolazine can be increased when it is combined with Verapamil.	#B4D1E6	0.250345790122607	1
Ketoconazole	Acenocoumarol	0.11	-3.346	None	8 (2/6)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#A9C9E1	1.00138316049043	1
Erythromycin	Carbamazepine	0.113	-1.487	Major	7 (3/4)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#B2D0E5	0.876210265429124	1
Theophylline	Acyclovir	0.307	-1.115	Minor	4 (2/2)		#B4D1E6	0.500691580245214	1
Rifabutin	Atorvastatin	0.081	-1.115	Moderate	2 (1/1)	The metabolism of Atorvastatin can be increased when combined with Rifabutin.	#B4D1E6	0.250345790122607	1
Galantamine	Cyclobenzaprine	0.037	Inf	Moderate	2 (2/0)		#B32020	0.250345790122607	1
Tacrolimus	Ketoconazole	0.333	Inf	Major	1 (1/0)	The serum concentration of Tacrolimus can be increased when it is combined with Ketoconazole.	#B32020	0.125172895061303	1
Hydrocortisone	Rifampicin	0.393	-2.231	Moderate	6 (2/4)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#AECDE3	0.751037370367821	1
Colestipol	Acenocoumarol	0.293	-5.02	None	11 (2/9)	Colestipol can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#A0C3DD	1.37690184567434	1
Cyclobenzaprine	Rivastigmine	0.085	1.345	Moderate	5 (3/2)		#F8BABA	0.625864475306517	1
Bisoprolol	Chlorpropamide	0.352	-1.115	Moderate	2 (1/1)	Bisoprolol may increase the hypoglycemic activities of Chlorpropamide.	#B4D1E6	0.250345790122607	1
Phenytoin	Betamethasone	0.026	Inf	Moderate	1 (1/0)	The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.	#B32020	0.125172895061303	1
Dextromethorphan	Terbinafine	0.341	-1.434	Major	16 (7/9)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#B2D0E5	2.00276632098085	1
Clozapine	Ciprofloxacin	0.082	-1.115	Major	2 (1/1)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#B4D1E6	0.250345790122607	1
Lansoprazole	Ketoconazole	0.166	-2.789	Moderate	7 (2/5)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#ACCCE3	0.876210265429124	1
Captopril	Lithium cation	0.15	1.793	Moderate	3 (2/1)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#F7B9B9	0.37551868518391	1
Betamethasone	Phenobarbital	0.025	Inf	Moderate	1 (1/0)	The serum concentration of Betamethasone can be decreased when it is combined with Phenobarbital.	#B32020	0.125172895061303	1
Indomethacin	Warfarin	0.169	-4.834	Major	16 (3/13)	Indomethacin may increase the anticoagulant activities of Warfarin.	#A2C4DE	2.00276632098085	1
Piroxicam	Acenocoumarol	0.134	-1.487	None	7 (3/4)	Piroxicam may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	0.876210265429124	1
Ketoconazole	Tolterodine	0.18	-2.231	Moderate	3 (1/2)	The serum concentration of Tolterodine can be increased when it is combined with Ketoconazole.	#AECDE3	0.37551868518391	1
Theophylline	Norfloxacin	0.276	-1.394	Moderate	9 (4/5)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#B2D0E5	1.12655605555173	1
Doxycycline	Carbamazepine	0.126	-2.231	Moderate	6 (2/4)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#AECDE3	0.751037370367821	1
Codeine	Naltrexone	0.05	-1.115	Major	4 (2/2)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#B4D1E6	0.500691580245214	1
Trifluoperazine	Levofloxacin	0.211	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Carbamazepine	Felodipine	0.386	-3.346	Moderate	4 (1/3)	The metabolism of Felodipine can be increased when combined with Carbamazepine.	#A9C9E1	0.500691580245214	1
Chlorpromazine	Levofloxacin	0.363	-5.02	Moderate	11 (2/9)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#A0C3DD	1.37690184567434	1
Metformin	Cimetidine	0.12	-3.346	Moderate	8 (2/6)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#A9C9E1	1.00138316049043	1
Amitriptyline	Cimetidine	0.177	-1.115	Moderate	2 (1/1)	The metabolism of Amitriptyline can be decreased when combined with Cimetidine.	#B4D1E6	0.250345790122607	1
Azithromycin	Disopyramide	0.073	-1.115	Major	2 (1/1)	Azithromycin may increase the QTc-prolonging activities of Disopyramide.	#B4D1E6	0.250345790122607	1
Moxifloxacin	Ziprasidone	0.187	-2.231	Major	3 (1/2)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#AECDE3	0.37551868518391	1
Ranitidine	Ketoconazole	0.289	-2.231	Moderate	6 (2/4)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#AECDE3	0.751037370367821	1
Ketoconazole	Quetiapine	0.329	-4.462	Major	5 (1/4)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#A3C5DF	0.625864475306517	1
Carbamazepine	Josamycin	0.077	Inf	None	1 (1/0)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#B32020	0.125172895061303	1
Naratriptan	Sertraline	0.176	-2.231	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertraline.	#AECDE3	0.37551868518391	1
Theophylline	Propranolol	0.345	-1.673	Major	5 (2/3)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#B1CFE5	0.625864475306517	1
Rifampicin	Nifedipine	0.109	-2.231	Major	3 (1/2)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#AECDE3	0.37551868518391	1
Clozapine	Alprazolam	0.713	-1.115	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#B4D1E6	0.250345790122607	1
Labetalol	Formoterol	0.062	-1.115	Major	2 (1/1)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#B4D1E6	0.250345790122607	1
Perindopril	Lithium cation	0.217	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Perindopril.	#B32020	0.125172895061303	1
Cyclosporine	Terbinafine	0.089	-2.231	Minor	3 (1/2)	The metabolism of Cyclosporine can be decreased when combined with Terbinafine.	#AECDE3	0.37551868518391	1
Primidone	Methylprednisolone	0.375	-1.115	Moderate	2 (1/1)	The serum concentration of Methylprednisolone can be decreased when it is combined with Primidone.	#B4D1E6	0.250345790122607	1
Nortriptyline	Terbinafine	0.141	-1.115	Moderate	2 (1/1)	The metabolism of Nortriptyline can be decreased when combined with Terbinafine.	#B4D1E6	0.250345790122607	1
Dihydroergotamine	Itraconazole	0.125	Inf	Major	2 (2/0)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#B32020	0.250345790122607	1
Ketoconazole	Budesonide	0.29	-2.975	Major	11 (3/8)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#ABCBE2	1.37690184567434	1
Phenytoin	Sucralfate	0.332	-3.346	Moderate	4 (1/3)		#A9C9E1	0.500691580245214	1
Erythromycin	Warfarin	0.084	-2.231	Major	6 (2/4)	The serum concentration of Warfarin can be increased when it is combined with Erythromycin.	#AECDE3	0.751037370367821	1
Pyridostigmine	Methylprednisolone	0.172	-2.231	Moderate	3 (1/2)	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Pyridostigmine.	#AECDE3	0.37551868518391	1
Methylprednisolone	Ketoconazole	1	-1.115	Major	2 (1/1)	The serum concentration of Methylprednisolone can be increased when it is combined with Ketoconazole.	#B4D1E6	0.250345790122607	1
Alfuzosin	Itraconazole	0.185	-15.617	Major	15 (1/14)	The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.	#6B9BC6	1.87759342591955	1
Salbutamol	Moclobemide	0.132	-1.115	None	2 (1/1)	The risk or severity of adverse effects can be increased when Moclobemide is combined with Salbutamol.	#B4D1E6	0.250345790122607	1
Tacrolimus	Rifampicin	0.115	-3.346	Major	4 (1/3)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#A9C9E1	0.500691580245214	1
Erythromycin	Sotalol	0.059	Inf	Major	1 (1/0)	Erythromycin may increase the QTc-prolonging activities of Sotalol.	#B32020	0.125172895061303	1
Fluvoxamine	Oxycodone	0.075	-3.346	Moderate	4 (1/3)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxycodone.	#A9C9E1	0.500691580245214	1
Warfarin	Itraconazole	0.098	-2.231	Moderate	6 (2/4)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#AECDE3	0.751037370367821	1
Trandolapril	Tizanidine	0.471	-1.115	Major	2 (1/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Trandolapril.	#B4D1E6	0.250345790122607	1
Glimepiride	Rifampicin	0.08	-1.115	Moderate	2 (1/1)	The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.	#B4D1E6	0.250345790122607	1
Nortriptyline	Pseudoephedrine	1	Inf	None	1 (1/0)	Nortriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.125172895061303	1
Prednisolone	Acenocoumarol	0.169	-3.346	None	4 (1/3)		#A9C9E1	0.500691580245214	1
Triamcinolone	Warfarin	0.105	-1.115	Moderate	4 (2/2)	Triamcinolone may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.500691580245214	1
Fluvoxamine	Tizanidine	0.333	Inf	Major	1 (1/0)	The serum concentration of Tizanidine can be increased when it is combined with Fluvoxamine.	#B32020	0.125172895061303	1
Tacrolimus	Felodipine	0.043	-2.231	Moderate	3 (1/2)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#AECDE3	0.37551868518391	1
Erythromycin	Rifampicin	1	-1.115	Moderate	2 (1/1)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#B4D1E6	0.250345790122607	1
Cyclosporine	Lovastatin	0.275	-4.462	Major	5 (1/4)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#A3C5DF	0.625864475306517	1
Fluvastatin	Bezafibrate	0.114	-4.462	None	5 (1/4)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#A3C5DF	0.625864475306517	1
Fluorouracil	Metronidazole	0.417	-1.115	Moderate	2 (1/1)	The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.	#B4D1E6	0.250345790122607	1
Hydrocortisone	Primidone	0.079	-1.115	Moderate	2 (1/1)	The serum concentration of Hydrocortisone can be decreased when it is combined with Primidone.	#B4D1E6	0.250345790122607	1
Doxycycline	Phenoxymethylpenicillin	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Doxycycline.	#B32020	0.125172895061303	1
Paroxetine	Naratriptan	0.36	-2.231	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#AECDE3	0.37551868518391	1
Warfarin	Meloxicam	0.097	-1.115	Major	4 (2/2)	Meloxicam may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.500691580245214	1
Diltiazem	Cilostazol	0.322	-59.12	Major	54 (1/53)	The serum concentration of Cilostazol can be increased when it is combined with Diltiazem.	#1E61A5	6.75933633331038	1
Simvastatin	Telithromycin	0.132	-1.673	Major	5 (2/3)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#B1CFE5	0.625864475306517	1
Minocycline	Acenocoumarol	0.161	-8.924	None	18 (2/16)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#8CB4D5	2.25311211110346	1
Griseofulvin	Acetylsalicylic acid	0.03	-2.231	Minor	3 (1/2)		#AECDE3	0.37551868518391	1
Rifampicin	Dexamethasone	0.593	-2.231	Moderate	3 (1/2)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#AECDE3	0.37551868518391	1
Dihydroergotamine	Isosorbide mononitrate	0.611	-2.231	Moderate	3 (1/2)	The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.	#AECDE3	0.37551868518391	1
Ofloxacin	Iron	0.586	-4.462	None	5 (1/4)		#A3C5DF	0.625864475306517	1
Sucralfate	Itraconazole	0.345	-2.231	None	6 (2/4)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#AECDE3	0.751037370367821	1
Colestipol	Hydrocortisone	0.19	Inf	Moderate	1 (1/0)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.125172895061303	1
Famotidine	Itraconazole	0.513	-1.115	Moderate	2 (1/1)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#B4D1E6	0.250345790122607	1
Repaglinide	Rifampicin	0.154	-6.693	Moderate	7 (1/6)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#99BDDA	0.876210265429124	1
Flurbiprofen	Acenocoumarol	0.126	-1.115	None	2 (1/1)	Flurbiprofen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.250345790122607	1
Theophylline	Terbinafine	0.184	-4.462	Moderate	5 (1/4)	The metabolism of Theophylline can be decreased when combined with Terbinafine.	#A3C5DF	0.625864475306517	1
Fluconazole	Nortriptyline	0.044	-1.115	Moderate	2 (1/1)	The metabolism of Nortriptyline can be decreased when combined with Fluconazole.	#B4D1E6	0.250345790122607	1
Phenobarbital	Estriol	0.167	Inf	None	1 (1/0)		#B32020	0.125172895061303	1
Indomethacin	Sotalol	0.156	-1.115	Moderate	2 (1/1)	Indomethacin may decrease the antihypertensive activities of Sotalol.	#B4D1E6	0.250345790122607	1
Fluconazole	Rifampicin	0.629	-5.577	Major	6 (1/5)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#9DC0DC	0.751037370367821	1
Epinephrine	Clomipramine	0.145	-1.115	Major	2 (1/1)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#B4D1E6	0.250345790122607	1
Labetalol	Salbutamol	0.177	-3.346	Major	4 (1/3)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#A9C9E1	0.500691580245214	1
Nortriptyline	Terbutaline	0.054	-2.231	Moderate	3 (1/2)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.	#AECDE3	0.37551868518391	1
Tramadol	Moclobemide	0.049	Inf	None	1 (1/0)	Tramadol may increase the neuroexcitatory activities of Moclobemide.	#B32020	0.125172895061303	1
Erythromycin	Midazolam	0.044	Inf	Moderate	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Erythromycin.	#B32020	0.125172895061303	1
Carbamazepine	Warfarin	0.175	-5.577	Moderate	6 (1/5)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#9DC0DC	0.751037370367821	1
Cyclosporine	Clindamycin	0.05	-5.577	Moderate	6 (1/5)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#9DC0DC	0.751037370367821	1
Fluphenazine	Levofloxacin	0.198	-2.231	Moderate	3 (1/2)		#AECDE3	0.37551868518391	1
Fluconazole	Eplerenone	0.08	-16.732	Moderate	16 (1/15)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#6596C4	2.00276632098085	1
Phenoxymethylpenicillin	Methotrexate	0.042	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Phenoxymethylpenicillin.	#B32020	0.125172895061303	1
Propranolol	Glipizide	0.22	-12.27	Moderate	12 (1/11)	Propranolol may increase the hypoglycemic activities of Glipizide.	#7CA7CD	1.50207474073564	1
Minocycline	Iron	0.093	-2.231	Moderate	3 (1/2)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#AECDE3	0.37551868518391	1
Codeine	Cimetidine	0.571	-1.115	Moderate	2 (1/1)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#B4D1E6	0.250345790122607	1
Trospium	Cyclobenzaprine	0.5	Inf	Moderate	1 (1/0)		#B32020	0.125172895061303	1
Amitriptyline	Ketoconazole	0.545	-1.115	Moderate	2 (1/1)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#B4D1E6	0.250345790122607	1
Isoniazid	Acenocoumarol	0.161	-21.194	None	20 (1/19)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#5086BA	2.50345790122607	1
Digoxin	Itraconazole	0.166	-6.135	Major	13 (2/11)	The serum concentration of Digoxin can be increased when it is combined with Itraconazole.	#9ABEDB	1.62724763579694	1
Erythromycin	Colchicine	0.527	-3.346	Major	4 (1/3)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#A9C9E1	0.500691580245214	1
Warfarin	Terbinafine	0.073	-5.577	Moderate	6 (1/5)		#9DC0DC	0.751037370367821	1
Warfarin	Etoricoxib	0.185	-2.231	None	6 (2/4)	Etoricoxib may increase the anticoagulant activities of Warfarin.	#AECDE3	0.751037370367821	1
Clonidine	Labetalol	0.955	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#1E61A5	0.125172895061303	1
Clozapine	Haloperidol	0.221	-Inf	Major	3 (0/3)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#1E61A5	0.37551868518391	1
Tobramycin	Ceftriaxone	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.125172895061303	1
Prazosin	Nadolol	0.736	-Inf	Moderate	2 (0/2)	Nadolol may increase the orthostatic hypotensive activities of Prazosin.	#1E61A5	0.250345790122607	1
Imipramine	Moclobemide	0.167	-Inf	None	1 (0/1)	Moclobemide may increase the serotonergic activities of Imipramine.	#1E61A5	0.125172895061303	1
Donepezil	Pimozide	0.277	-Inf	Moderate	2 (0/2)		#1E61A5	0.250345790122607	1
Fluvoxamine	Clozapine	0.062	-Inf	Moderate	1 (0/1)	The serum concentration of Clozapine can be increased when it is combined with Fluvoxamine.	#1E61A5	0.125172895061303	1
Dapsone	Rifampicin	0.167	-Inf	Moderate	1 (0/1)	The metabolism of Dapsone can be increased when combined with Rifampicin.	#1E61A5	0.125172895061303	1
Aprepitant	Dexamethasone	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Dexamethasone can be increased when it is combined with Aprepitant.	#1E61A5	0.125172895061303	1
Testosterone	Acenocoumarol	0.282	-Inf	None	57 (0/57)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	7.13485501849429	1
Trihexyphenidyl	Rivastigmine	0.455	-Inf	Moderate	3 (0/3)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Rivastigmine.	#1E61A5	0.37551868518391	1
Chlorpromazine	Donepezil	0.085	-Inf	Moderate	4 (0/4)	The metabolism of Donepezil can be decreased when combined with Chlorpromazine.	#1E61A5	0.500691580245214	1
Cimetidine	Ketoconazole	0.25	-Inf	Moderate	1 (0/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Cimetidine.	#1E61A5	0.125172895061303	1
Doxycycline	Aztreonam	1	-Inf	None	1 (0/1)		#1E61A5	0.125172895061303	1
Ethinylestradiol	Itraconazole	0.2	-Inf	Moderate	1 (0/1)	The metabolism of Ethinyl Estradiol can be decreased when combined with Itraconazole.	#1E61A5	0.125172895061303	1
Buspirone	Verapamil	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Buspirone can be decreased when combined with Verapamil.	#1E61A5	0.125172895061303	1
Doxycycline	Isotretinoin	0.133	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#1E61A5	0.250345790122607	1
Fluconazole	Vincristine	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Vincristine can be decreased when combined with Fluconazole.	#1E61A5	0.125172895061303	1
Mirtazapine	Clonidine	0.135	-Inf	Moderate	2 (0/2)	Mirtazapine may decrease the antihypertensive activities of Clonidine.	#1E61A5	0.250345790122607	1
Carbamazepine	Norethisterone	0.048	-Inf	Major	1 (0/1)	The metabolism of Norethisterone can be increased when combined with Carbamazepine.	#1E61A5	0.125172895061303	1
Selegiline	Escitalopram	0.482	-Inf	Major	5 (0/5)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#1E61A5	0.625864475306517	1
Clonidine	Clomipramine	0.231	-Inf	Major	1 (0/1)	Clomipramine may decrease the antihypertensive activities of Clonidine.	#1E61A5	0.125172895061303	1
Digoxin	Sulfasalazine	0.297	-Inf	Moderate	7 (0/7)	The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.	#1E61A5	0.876210265429124	1
Metoprolol	Hydralazine	0.226	-Inf	Minor	6 (0/6)	Hydralazine may increase the hypotensive activities of Metoprolol.	#1E61A5	0.751037370367821	1
Acetylsalicylic acid	Heparin	0.11	-Inf	Moderate	4 (0/4)	Acetylsalicylic acid may increase the anticoagulant activities of Heparin.	#1E61A5	0.500691580245214	1
Clozapine	Carbamazepine	1	-Inf	Major	1 (0/1)	Carbamazepine may increase the myelosuppressive activities of Clozapine.	#1E61A5	0.125172895061303	1
Donepezil	Periciazine	0.222	-Inf	None	1 (0/1)		#1E61A5	0.125172895061303	1
Galantamine	Zuclopenthixol	1	-Inf	None	1 (0/1)	Galantamine may increase the QTc-prolonging activities of Zuclopenthixol.	#1E61A5	0.125172895061303	1
Cimetidine	Rivastigmine	0.111	-Inf	Moderate	1 (0/1)		#1E61A5	0.125172895061303	1
Repaglinide	Oxprenolol	0.079	-Inf	None	2 (0/2)		#1E61A5	0.250345790122607	1
Carbamazepine	Danazol	0.455	-Inf	Moderate	1 (0/1)	The metabolism of Carbamazepine can be decreased when combined with Danazol.	#1E61A5	0.125172895061303	1
Labetalol	Glyburide	0.125	-Inf	Moderate	4 (0/4)	Labetalol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.500691580245214	1
Fludrocortisone	Primidone	0.143	-Inf	Moderate	1 (0/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Primidone.	#1E61A5	0.125172895061303	1
Eplerenone	Tolevamer	0.236	-Inf	None	7 (0/7)		#1E61A5	0.876210265429124	1
Lovastatin	Josamycin	0.044	-Inf	None	4 (0/4)	The serum concentration of Lovastatin can be increased when it is combined with Josamycin.	#1E61A5	0.500691580245214	1
Trihexyphenidyl	Galantamine	0.76	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Galantamine.	#1E61A5	0.125172895061303	1
Citalopram	Clozapine	0.115	-Inf	Major	2 (0/2)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#1E61A5	0.250345790122607	1
Fluconazole	Phenytoin	0.149	-Inf	Moderate	8 (0/8)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#1E61A5	1.00138316049043	1
Ticlopidine	Phenytoin	0.766	-Inf	Moderate	2 (0/2)	The serum concentration of Phenytoin can be increased when it is combined with Ticlopidine.	#1E61A5	0.250345790122607	1
Digoxin	Telithromycin	0.07	-Inf	Moderate	2 (0/2)	The metabolism of Digoxin can be decreased when combined with Telithromycin.	#1E61A5	0.250345790122607	1
Trospium	Galantamine	0.5	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Trospium can be decreased when used in combination with Galantamine.	#1E61A5	0.125172895061303	1
Citalopram	Moclobemide	0.448	-Inf	None	2 (0/2)	The serum concentration of Citalopram can be increased when it is combined with Moclobemide.	#1E61A5	0.250345790122607	1
Disopyramide	Propranolol	0.786	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Propranolol.	#1E61A5	0.125172895061303	1
Phenytoin	Prednisolone	0.25	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisolone can be decreased when it is combined with Phenytoin.	#1E61A5	0.125172895061303	1
Dextromethorphan	Moclobemide	0.061	-Inf	None	2 (0/2)	Moclobemide may increase the serotonergic activities of Dextromethorphan.	#1E61A5	0.250345790122607	1
Theophylline	Cimetidine	0.04	-Inf	Moderate	1 (0/1)	The metabolism of Theophylline can be decreased when combined with Cimetidine.	#1E61A5	0.125172895061303	1
Phenytoin	Rifampicin	0.101	-Inf	Major	3 (0/3)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#1E61A5	0.37551868518391	1
Cimetidine	Clonazepam	0.253	-Inf	Moderate	2 (0/2)		#1E61A5	0.250345790122607	1
Dihydroergotamine	Isosorbide dinitrate	0.071	-Inf	Moderate	1 (0/1)	The metabolism of Isosorbide Dinitrate can be decreased when combined with Dihydroergotamine.	#1E61A5	0.125172895061303	1
Glipizide	Nadolol	0.114	-Inf	Moderate	2 (0/2)	Nadolol may increase the hypoglycemic activities of Glipizide.	#1E61A5	0.250345790122607	1
Furosemide	Streptomycin	0.077	-Inf	Major	1 (0/1)	The serum concentration of Streptomycin can be increased when it is combined with Furosemide.	#1E61A5	0.125172895061303	1
Labetalol	Terbutaline	0.027	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Labetalol is combined with Terbutaline.	#1E61A5	0.250345790122607	1
Benazepril	Tizanidine	0.091	-Inf	Major	1 (0/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Benazepril.	#1E61A5	0.125172895061303	1
Metoprolol	Piroxicam	0.04	-Inf	Moderate	2 (0/2)	Piroxicam may decrease the antihypertensive activities of Metoprolol.	#1E61A5	0.250345790122607	1
Propranolol	Clonidine	0.021	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#1E61A5	0.125172895061303	1
Midazolam	Rifampicin	0.203	-Inf	Minor	2 (0/2)	The metabolism of Midazolam can be increased when combined with Rifampicin.	#1E61A5	0.250345790122607	1
Mercaptopurine	Acenocoumarol	0.364	-Inf	None	3 (0/3)	Mercaptopurine may decrease the anticoagulant activities of Acenocoumarol.	#1E61A5	0.37551868518391	1
Chlorpromazine	Galantamine	0.036	-Inf	Moderate	1 (0/1)	The metabolism of Galantamine can be decreased when combined with Chlorpromazine.	#1E61A5	0.125172895061303	1
Warfarin	Mercaptopurine	0.03	-Inf	Moderate	1 (0/1)	Mercaptopurine may decrease the anticoagulant activities of Warfarin.	#1E61A5	0.125172895061303	1
Telithromycin	Acenocoumarol	0.081	-Inf	None	3 (0/3)	The metabolism of Acenocoumarol can be decreased when combined with Telithromycin.	#1E61A5	0.37551868518391	1
Doxycycline	Insulin glulisine	0.091	-Inf	Moderate	4 (0/4)		#1E61A5	0.500691580245214	1
Disulfiram	Metronidazole	0.206	-Inf	Major	6 (0/6)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#1E61A5	0.751037370367821	1
Trihexyphenidyl	Donepezil	0.212	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Donepezil.	#1E61A5	0.125172895061303	1
Phenytoin	Flurazepam	0.647	-Inf	Moderate	2 (0/2)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#1E61A5	0.250345790122607	1
Fludrocortisone	Rifampicin	0.263	-Inf	Moderate	1 (0/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Rifampicin.	#1E61A5	0.125172895061303	1
Cyclosporine	Oxcarbazepine	0.197	-Inf	Moderate	2 (0/2)		#1E61A5	0.250345790122607	1
Fluoxetine	Selegiline	0.105	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Selegiline.	#1E61A5	0.250345790122607	1
Methotrexate	Ketoprofen	0.321	-Inf	Major	2 (0/2)	The serum concentration of Methotrexate can be increased when it is combined with Ketoprofen.	#1E61A5	0.250345790122607	1
Digoxin	Cyclophosphamide	0.302	-Inf	Moderate	2 (0/2)	Digoxin may decrease the cardiotoxic activities of Cyclophosphamide.	#1E61A5	0.250345790122607	1
Glimepiride	Ketoconazole	0.187	-Inf	None	3 (0/3)	The metabolism of Glimepiride can be decreased when combined with Ketoconazole.	#1E61A5	0.37551868518391	1
Famotidine	Ketoconazole	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Famotidine.	#1E61A5	0.125172895061303	1
Primidone	Felodipine	0.9	-Inf	Moderate	1 (0/1)	The metabolism of Felodipine can be increased when combined with Primidone.	#1E61A5	0.125172895061303	1
Fluconazole	Cilostazol	0.107	-Inf	Major	8 (0/8)	The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.	#1E61A5	1.00138316049043	1
Rosiglitazone	Ketoconazole	0.111	-Inf	Moderate	1 (0/1)	The metabolism of Rosiglitazone can be decreased when combined with Ketoconazole.	#1E61A5	0.125172895061303	1
Labetalol	Gliclazide	0.175	-Inf	None	3 (0/3)	Labetalol may increase the hypoglycemic activities of Gliclazide.	#1E61A5	0.37551868518391	1
Labetalol	Verapamil	0.077	-Inf	Major	1 (0/1)	Verapamil may increase the hypotensive activities of Labetalol.	#1E61A5	0.125172895061303	1
Phenytoin	Sirolimus	0.154	-Inf	Major	1 (0/1)	The serum concentration of Sirolimus can be decreased when it is combined with Phenytoin.	#1E61A5	0.125172895061303	1
Epinephrine	Rasagiline	0.269	-Inf	Moderate	2 (0/2)	Rasagiline may increase the hypertensive activities of Epinephrine.	#1E61A5	0.250345790122607	1
Sulindac	Furosemide	0.619	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulindac.	#1E61A5	0.125172895061303	1
Cimetidine	Diazepam	0.526	-Inf	Moderate	3 (0/3)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#1E61A5	0.37551868518391	1
Nortriptyline	Rasagiline	0.5	-Inf	Major	1 (0/1)	Rasagiline may increase the serotonergic activities of Nortriptyline.	#1E61A5	0.125172895061303	1
Naltrexone	Fentanyl	0.557	-Inf	Major	2 (0/2)	The therapeutic efficacy of Fentanyl can be decreased when used in combination with Naltrexone.	#1E61A5	0.250345790122607	1
Cimetidine	Nifedipine	0.027	-Inf	Moderate	1 (0/1)	The serum concentration of Nifedipine can be increased when it is combined with Cimetidine.	#1E61A5	0.125172895061303	1
Eplerenone	Lithium cation	0.125	-Inf	Moderate	3 (0/3)	The serum concentration of Lithium can be increased when it is combined with Eplerenone.	#1E61A5	0.37551868518391	1
Cilostazol	Itraconazole	0.155	-Inf	Major	6 (0/6)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#1E61A5	0.751037370367821	1
Piroxicam	Nadolol	0.4	-Inf	Moderate	1 (0/1)	Piroxicam may decrease the antihypertensive activities of Nadolol.	#1E61A5	0.125172895061303	1
Ranolazine	Clarithromycin	0.082	-Inf	Major	6 (0/6)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#1E61A5	0.751037370367821	1
Doxycycline	Ampicillin	1	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Ampicillin can be decreased when used in combination with Doxycycline.	#1E61A5	0.125172895061303	1
Ampicillin	Warfarin	0.071	-Inf	Moderate	1 (0/1)	Ampicillin may increase the anticoagulant activities of Warfarin.	#1E61A5	0.125172895061303	1
Fluconazole	Triazolam	0.158	-Inf	Major	1 (0/1)	The metabolism of Triazolam can be decreased when combined with Fluconazole.	#1E61A5	0.125172895061303	1
Erythromycin	Cilostazol	0.247	-Inf	Major	4 (0/4)	The serum concentration of Cilostazol can be increased when it is combined with Erythromycin.	#1E61A5	0.500691580245214	1
Theophylline	Primidone	0.077	-Inf	Moderate	1 (0/1)	The metabolism of Theophylline can be increased when combined with Primidone.	#1E61A5	0.125172895061303	1
Tetracycline	Insulin glulisine	0.042	-Inf	Moderate	1 (0/1)		#1E61A5	0.125172895061303	1
Phenylbutazone	Glyburide	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.125172895061303	1
Primidone	Dexamethasone	0.059	-Inf	Moderate	2 (0/2)	The serum concentration of Dexamethasone can be decreased when it is combined with Primidone.	#1E61A5	0.250345790122607	1
Galantamine	Tizanidine	0.023	-Inf	Moderate	1 (0/1)	Galantamine may increase the bradycardic activities of Tizanidine.	#1E61A5	0.125172895061303	1
Warfarin	Rifampicin	0.085	-Inf	Major	2 (0/2)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#1E61A5	0.250345790122607	1
Warfarin	Minocycline	0.087	-Inf	Moderate	2 (0/2)	Minocycline may increase the anticoagulant activities of Warfarin.	#1E61A5	0.250345790122607	1
Ketoconazole	Pioglitazone	0.042	-Inf	Moderate	1 (0/1)	The metabolism of Pioglitazone can be decreased when combined with Ketoconazole.	#1E61A5	0.125172895061303	1
Erythromycin	Cabergoline	0.023	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#1E61A5	0.125172895061303	1
Ketoconazole	Solifenacin	0.264	-Inf	Major	2 (0/2)	The metabolism of Solifenacin can be decreased when combined with Ketoconazole.	#1E61A5	0.250345790122607	1
Cyclosporine	Nabumetone	0.033	-Inf	Moderate	1 (0/1)	Nabumetone may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.125172895061303	1
Cyclosporine	Glipizide	0.097	-Inf	Moderate	1 (0/1)	The metabolism of Glipizide can be decreased when combined with Cyclosporine.	#1E61A5	0.125172895061303	1
Carbamazepine	Ketoconazole	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#1E61A5	0.125172895061303	1
Testosterone	Warfarin	0.084	-Inf	Major	3 (0/3)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.37551868518391	1
Tobramycin	Cefuroxime	0.167	-Inf	Moderate	1 (0/1)		#1E61A5	0.125172895061303	1
Cyclosporine	Nicardipine	0.379	-Inf	Moderate	1 (0/1)	The metabolism of Nicardipine can be decreased when combined with Cyclosporine.	#1E61A5	0.125172895061303	1
Salmeterol	Oxprenolol	0.25	-Inf	None	1 (0/1)	Oxprenolol may decrease the bronchodilatory activities of Salmeterol.	#1E61A5	0.125172895061303	1
Cyclosporine	Propafenone	0.167	-Inf	Minor	1 (0/1)	The serum concentration of Propafenone can be increased when it is combined with Cyclosporine.	#1E61A5	0.125172895061303	1
Fosinopril	Lithium cation	1	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Fosinopril.	#1E61A5	0.125172895061303	1
Megestrol acetate	Primidone	0.026	-Inf	Moderate	1 (0/1)		#1E61A5	0.125172895061303	1
Glycopyrronium	Rivastigmine	0.343	-Inf	None	2 (0/2)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.	#1E61A5	0.250345790122607	1
Eplerenone	Itraconazole	0.128	-Inf	Major	4 (0/4)	The serum concentration of Eplerenone can be increased when it is combined with Itraconazole.	#1E61A5	0.500691580245214	1
Haloperidol	Glycopyrronium	0.05	-Inf	Moderate	3 (0/3)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#1E61A5	0.37551868518391	1
Phenytoin	Isoniazid	0.025	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Isoniazid.	#1E61A5	0.125172895061303	1
Repaglinide	Josamycin	0.05	-Inf	None	2 (0/2)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#1E61A5	0.250345790122607	1
Ketoprofen	Acenocoumarol	0.049	-Inf	None	3 (0/3)	Ketoprofen may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.37551868518391	1
Cyclosporine	Bupropion	0.556	-Inf	Moderate	1 (0/1)	The metabolism of Bupropion can be decreased when combined with Cyclosporine.	#1E61A5	0.125172895061303	1
Rifampicin	Itraconazole	0.5	-Inf	Major	2 (0/2)	The serum concentration of Itraconazole can be decreased when it is combined with Rifampicin.	#1E61A5	0.250345790122607	1
Ergotamine	Isosorbide mononitrate	0.063	-Inf	Moderate	2 (0/2)		#1E61A5	0.250345790122607	1
Doxycycline	Primidone	0.222	-Inf	Moderate	1 (0/1)	The serum concentration of Doxycycline can be decreased when it is combined with Primidone.	#1E61A5	0.125172895061303	1
Trospium	Glycopyrronium	0.4	-Inf	Moderate	1 (0/1)	Trospium may increase the anticholinergic activities of Glycopyrronium.	#1E61A5	0.125172895061303	1
Clozapine	Diazepam	0.04	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#1E61A5	0.125172895061303	1
Pimozide	Clarithromycin	0.062	-Inf	Major	1 (0/1)	The risk or severity of ventricular arrhythmias can be increased when Clarithromycin is combined with Pimozide.	#1E61A5	0.125172895061303	1
Ketoconazole	Cilostazol	0.02	-Inf	Major	1 (0/1)	The serum concentration of Cilostazol can be increased when it is combined with Ketoconazole.	#1E61A5	0.125172895061303	1
Warfarin	Dexamethasone	0.345	-Inf	Moderate	4 (0/4)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.500691580245214	1
Phenylbutazone	Acenocoumarol	0.097	-Inf	None	1 (0/1)	Phenylbutazone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.125172895061303	1
Isotretinoin	Acenocoumarol	0.059	-Inf	None	1 (0/1)		#1E61A5	0.125172895061303	1
Cyclosporine	Glimepiride	0.288	-Inf	Moderate	2 (0/2)	The metabolism of Glimepiride can be decreased when combined with Cyclosporine.	#1E61A5	0.250345790122607	1
Galantamine	Glycopyrronium	0.174	-Inf	None	1 (0/1)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Galantamine.	#1E61A5	0.125172895061303	1
Theophylline	Propafenone	0.625	-Inf	Moderate	1 (0/1)	The serum concentration of Theophylline can be increased when it is combined with Propafenone.	#1E61A5	0.125172895061303	1
Verapamil	Nadolol	1	-Inf	Major	1 (0/1)	Verapamil may increase the hypotensive activities of Nadolol.	#1E61A5	0.125172895061303	1
Oxytetracycline	Amoxicillin	0.5	-Inf	Moderate	1 (0/1)		#1E61A5	0.125172895061303	1
Cyclosporine	Erythromycin	0.033	-Inf	Major	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Erythromycin.	#1E61A5	0.125172895061303	1
Dextromethorphan	Selegiline	0.05	-Inf	Major	1 (0/1)	Selegiline may increase the serotonergic activities of Dextromethorphan.	#1E61A5	0.125172895061303	1
Primidone	Metronidazole	1	-Inf	Moderate	1 (0/1)	The serum concentration of Metronidazole can be decreased when it is combined with Primidone.	#1E61A5	0.125172895061303	1
Erythromycin	Ranolazine	1	-Inf	Major	1 (0/1)	The serum concentration of Ranolazine can be increased when it is combined with Erythromycin.	#1E61A5	0.125172895061303	1
Terbinafine	Rifampicin	0.25	-Inf	Minor	1 (0/1)	The serum concentration of Terbinafine can be decreased when it is combined with Rifampicin.	#1E61A5	0.125172895061303	1
Digoxin	Tetracycline	0.091	-Inf	Moderate	1 (0/1)		#1E61A5	0.125172895061303	1
Rifampicin	Fluvastatin	0.161	-Inf	Moderate	1 (0/1)	The metabolism of Fluvastatin can be increased when combined with Rifampicin.	#1E61A5	0.125172895061303	1
Sirolimus	Clarithromycin	0.071	-Inf	Major	1 (0/1)	The metabolism of Sirolimus can be decreased when combined with Clarithromycin.	#1E61A5	0.125172895061303	1
Ranolazine	Itraconazole	1	-Inf	Major	1 (0/1)	The serum concentration of Ranolazine can be increased when it is combined with Itraconazole.	#1E61A5	0.125172895061303	1
Tenoxicam	Acenocoumarol	0.333	-Inf	None	1 (0/1)	Tenoxicam may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.125172895061303	1
